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ABSTRACT 
 
1,1,1-trichloro-2,2-bis(4-methoxyphenyl)ethane (methoxychlor; MXC) is an 
organochlorine pesticide used against pests and insects that attack crops, gardens, vegetables, 
pets, and livestock. MXC targets the ovary and its exposure has adverse effects on reproductive 
function in adult female mice causing persistent estrus, reduced fertility, and ovarian atrophy. 
MXC reduces fertility by increasing atresia of antral follicles and by decreasing numbers of 
healthy antral follicles in adult female mice. Further, MXC inhibits growth and induces atresia of 
mouse antral follicles in vitro.  Little is known, however, about the mechanisms by which MXC 
causes slow growth and atresia of antral follicles. Hence, this dissertation work was designed to 
help us to better understand the mechanism of action of MXC in antral follicles by examining the 
effects of MXC on steroid levels, Bcl2 factors and caspase activity, and by determining if MXC 
exerts toxicity through an AHR pathway. Since MXC is known to target antral follicles, the 
major producer of sex steroids in the ovary, the present study first tested the hypothesis that 
MXC decreases estradiol (E2) levels by altering steroidogenic and metabolic enzymes in the 
antral follicles. Given that MXC induces atresia after long term exposure, in part, by increasing 
the pro-apoptotic factor Bax and decreasing the anti-apoptotic factor Bcl2 in antral follicles, the 
present study also tested the hypothesis that MXC induces atresia at early time points and alters 
other pro-apoptotic (Bok and Casp3) and anti-apoptotic factors (Bcl-xL) in addition to Bcl2 and 
Bax. In addition, the present study tested the hypothesis that MXC alters caspase activity in the 
follicles. Several studies indicate that many chemicals act through the aryl hydrocarbon receptor 
(AHR) pathway and one study has shown that MXC binds to the AHR in liver cells. Hence, the 
present work also tested the hypothesis that MXC binds to the AHR to inhibit follicle growth and 
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induce atresia of antral follicles. To test these hypotheses, antral follicles were isolated from 
ovaries of female wild-type (WT) or AHR knock-out (AHRKO) mice and cultured with either 
vehicle (dimethylsulfoxide; DMSO) or MXC. Follicle growth was measured every 24 h for 96 or 
168 h. In addition, sex steroid hormone levels were measured using enzyme-linked 
immunosorbent assays (ELISA) and mRNA expression levels of steroidogenic enzymes, the E2 
metabolic enzyme Cyp1b1, and Bcl2 related factors were measured using qPCR. Caspase activity 
and atresia were also measured in follicles. In granulosa cells, MXC binding to AHR was also 
measured using transfection experiments. The results indicate that MXC decreases most of 
steroidogenic enzymes, increases metabolic enzyme expression and this in turn leads to 
decreased sex steroid hormone levels. The results also indicate that, at 24 h, MXC increases Bax 
levels and does not affect Bcl2 levels. This increases the Bax/Bcl2 ratio, which in turn may 
increase the mitochondrial permeability leading to activation of caspase activities. Thus, these 
early changes in Bax expression and caspase may induce onset of morphological atresia 
beginning at 48 h. Further, the results indicate MXC binds to the AHR in granulosa cells and that 
MXC (10, 100 μg/ml) significantly inhibits follicular growth in WT antral follicles by 168 h. The 
results also indicate that MXC (10,100μg/ml) significantly induces atresia in WT antral follicles. 
Conversely, MXC (10 μg/ml) did not significantly inhibit growth or induce atresia in AHRKO 
follicles. These data indicate that AHR deletion protects antral follicles against MXC-induced 
growth inhibition and atresia. Thus, this study suggests that MXC acts through the AHR pathway 
to inhibit follicle growth and induce atresia in antral follicles of the ovary. Collectively, this 
dissertation work has shown that MXC exerts toxicity in antral follicles by inhibiting 
steroidogenesis and inducing apoptosis, Further, this work shows that MXC may exert toxicity 
via an AHR pathway.  
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CHAPTER I 
 
1.1 Introduction 
The mammalian ovary contains a fixed number of different follicle types known as 
primordial, primary, pre-antral, and antral follicles. Follicles must grow from the primordial to 
the antral stage to be capable of ovulation and estrogen secretion. Thus, antral follicles play an 
important role in regulation of normal menstrual/estrous cyclicity, maintenance of the 
reproductive tract, and fertility. This follicle type is comprised of an oocyte, granulosa cells, and 
theca cells. The granulosa and thecal cells are responsible for production of endocrine hormones 
such as estradiol (E2) (Hirshfield, 1991). 
Many chemicals are known to be present in the environment. These environmental 
chemicals either directly affect reproductive tissues by mimicking endogenous hormones or 
indirectly affect reproductive tissues after conversion of the parent compound to an active 
metabolite, which then  acts as an endocrine disrupting chemical (EDC). Animal studies have 
shown that in utero exposure of certain EDCs affects the development of the female reproductive 
system. Human beings and some wild-life species are exposed to a wide variety of chemicals 
through food and water. Humans may also be exposed through their occupation. Some chemicals 
that act as EDCs include plasticizers, pesticides, phytoestrogens, and dioxins.  
The ovary is an important reproductive tissue involved in ovulation and steroidogenesis, 
and it contains follicles at different stages of development from primordial to antral follicles. 
Some EDCs target specific stages of follicle development in the ovary. The susceptibility of the 
follicles to harmful effects of a chemical depends on the stage of the follicle, duration of 
exposure, and the concentration that reaches the follicle (Sharara et al., 1998; Borgeest et al., 
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2002). EDCs such as benzo(a)pyrene affect primordial and primary follicles (Mattison et al., 
1989). Heavy metals such as lead and cadmium affect all stages of follicles (Taupeau et al., 
2001; Junaid, 1997). 4-vinylcyclohexene (VCH) and 4-vinylcyclohexene diepoxide (VCD) affect 
primordial and primary follicles (Thompson et al., 2005; Smith et al., 1990; Flaws et al., 1994).  
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) affects pre-antral and antral follicles (Heimler et 
al., 1998). Organochlorine pesticides such as dichlorodiphenyltrichloroethane (DDT), kepone, 
lindane, and dieldrin affect many different stages of follicles (Reigart et al. 1999).  
1,1,1-trichloro-2,2-bis(4-methoxyphenyl)ethane (methoxychlor; MXC) is a pesticide that 
is known to target antral follicles. It is widely used in many parts of the world against insects or 
pests that attack crops, gardens, fruits, vegetables and animals. MXC use became widespread in 
the 1970s after the popular chlorinated pesticide DDT was banned in the US and other parts of 
the world. MXC enters the environment when it is sprayed on crops, fruits or forests. When it is 
aerially sprayed, MXC contaminates wide areas including bodies of water and it travels to distant 
areas through wind or running water. Thus, air, water or foods are the main sources of MXC 
exposures for human beings and wild-life species.  
  MXC decreases antral follicle growth, which may lead to decreased capacity to ovulate and 
thus, affecting fertility (Miller et al., 2005; Swartz and Eroschenko, 1998). MXC also targets and 
destroys antral follicles by causing atresia (death via apoptosis) (Borgeest et al., 2002).  An 
increased rate of atresia may result in infertility as well as premature or early onset of menopause 
or reproductive senescence. Premature or early onset of menopause is a concern because it has 
been associated with an increased risk of chronic diseases such as osteoporosis and 
cardiovascular disease (Britt and Findlay, 2002; Couse and Korach, 1998; Findlay et al., 2001). 
While previous studies indicate that MXC slows follicle growth and destroys follicles by causing 
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atresia (Borgeest et al., 2002), the mechanism by which MXC slows follicle growth and 
increases atresia is unknown. Thus, the goal of this dissertation work was to understand the 
mechanistic pathways by which MXC causes toxicity in antral follicles. Specifically, I tested the 
following three main hypotheses: (1) MXC causes toxicity in antral follicles by inhibiting 
steroidogenesis via altering steroidogenic and metabolic enzymes, (2) MXC induces atresia of 
antral follicles by altering Bcl2 members and caspase activity, and (3) MXC causes atresia and 
inhibits follicle growth through an aryl hydrocarbon receptor (AHR) pathway. 
  The present chapter details the overview of the entire dissertation. In chapter II, I have 
described the significance and background for the project, including the importance of the study, 
routes of exposure, levels of exposure, and endocrine disruptive activities caused by MXC. In 
chapter III, I have described the work related to the hypothesis that MXC alters steroid levels by 
altering steroidogenic as well as metabolic enzymes in antral follicles. In chapter IV, I have 
described the work related to the hypothesis that MXC induces atresia by altering expression of 
Bcl2 family members and caspase activity. In chapter V, I have described the work related to the 
hypothesis that MXC inhibits follicle growth and induces atresia by acting through the AHR 
pathway. In chapter VI, I have explained the complete mechanism of action of MXC derived 
from our studies. In addition, I have discussed the potential pitfalls and propose future studies to 
complete our work so that we can better understand the mechanism of action of MXC. 
  To test the three main hypotheses of the dissertation, I completed the following specific 
aims:  
Specific aim1: To determine whether MXC alters E2 levels by regulation of synthesis and/or 
metabolism of E2 in antral follicles 
 To complete this aim, I cultured antral follicles isolated from CD1 mouse ovaries for 24, 
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48, and 96 h with vehicle control (dimethylsulfoxide; DMSO) or varying concentrations of MXC 
(1, 10, 100 g/ml). I then tested whether MXC decreases sex steroid levels in antral follicles and 
found that it reduces E2, testosterone, and androstenedione levels. I then tested whether MXC 
decreases E2 levels by altering synthetic as well as metabolic enzymes. I found that MXC 
decreases most of the E2 synthetic enzymes and increases the metabolic enzyme Cyp1b1. 
Collectively, these data show that MXC inhibits steroidogenesis by inhibiting expression of 
synthetic enzymes and inducing expression of metabolic enzymes.  
 
Specific aim 2: To determine whether MXC induces atresia by altering pro- and anti-
apoptotic factors and caspase activity in antral follicles. 
 To complete this aim, I cultured antral follicles isolated from CD1 mouse ovaries for 24, 
48, and 96 h. I first tested whether MXC induces atresia in antral follicles and found that MXC 
induces atresia as early as 48 h. I then tested whether MXC decreases anti-apoptotic factors 
(Bcl2, Bcl2-xL) and increases the pro-apoptotic factors (Bax, Bok) in antral follicles during 
induction of atresia. I found that MXC decreases expression of an important anti-apoptotic factor 
(Bcl2) and increases the pro-apoptotic factor (Bax) in follicles. In addition, I found that MXC 
induces caspase activities in antral follicles at all time points. Collectively, these data suggest 
that MXC induces atresia by increasing the ratio of Bax/Bcl2 and inducing caspase activity.  
 
Specific aim 3: To determine whether MXC inhibits the growth and induces atresia of 
antral follicles through the AHR pathway.  
 To complete this aim, I first tested whether MXC binds to AHR in ovarian cells. Briefly, 
I transfected granulosa cells with a xenobiotic response element (XRE) promoter containing 
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plasmid and found that MXC induces XREs similar to the positive control chemical TCDD.  
Next, I compared the ability of MXC to inhibit follicle growth and induce atresia in wild-type 
(WT) and AHR knockout (AHRKO) mice. I found that MXC (10 g/ml) inhibits follicle growth 
and induce atresia in WT, but not in AHRKO follicles. Collectively, these results suggest that 
MXC inhibits follicle growth and induces atresia through an AHR pathway.  
Below is the model that summarizes the main hypotheses tested in this dissertation project.  
 
1.2 Figures 
 
Figure 1.1 Model of action of MXC in antral follicles 
 
 
 
 E2 levels
Inhibits Follicle Growth
Induces  Follicular Atresia
 E2 synthesis enzymes
 E2 metabolic enzymes
AHR
 Anti‐apoptotic factors
 Pro‐apoptotic factors
MXC
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CHAPTER II 
 
Significance and Background 
 
2.1 Significance 
 MXC targets and destroys the antral follicles in the ovary (Borgeest et al., 2002; Swartz 
and Eroschenko, 1998; Swartz and Corkern, 1992). Specifically, MXC causes atresia (death via 
apoptosis) of antral follicles. This is of concern because antral follicles are the structural and 
functional units of the ovary and each mammalian ovary contains a finite number of antral 
follicles. The antral follicles have the ability to release eggs for fertilization and to produce sex 
steroid hormones. The sex steroid hormones produced by follicles are important for regulating 
the menstrual/estrous cycle, maintaining the reproductive tract, and initiating and maintaining 
pregnancy (Hirshfield, 1991). Chemicals such as MXC increase the rate at which follicles are 
depleted from the ovary by the process of atresia, resulting in an early menopause or early 
reproductive senescence. Further, atresia of antral follicles ablates fertility. The mechanism by 
which MXC increases atresia, however, is unknown. 
  The current work is significant because it tested whether the mechanism of MXC-induced 
toxicity involves effects of MXC on steroidogenesis and/or apoptosis and whether it involves 
AHR pathways. Thus, the current studies greatly improved our understanding of the mechanisms 
by which MXC damages the ovary, and in turn, this improved understanding may lead to the 
development of novel targets for the treatment and/or prevention of infertility induced by 
environmental chemical exposures. The present work is also significant because MXC is an 
excellent model compound for investigating the effects of an agent that modulates endocrine 
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pathways. Thus, the current studies also have increased our understanding of the mechanisms by 
which endocrine disruption adversely affects ovarian function. In addition, our studies with 
MXC lead to further insights into the ligand specificity for AHR; thereby increasing our 
understanding of the physiological and toxicological roles of the receptor. This improved 
understanding may lead to the development of novel ligands for the AHR, which may be used to 
treat infertility or may be used as contraceptive agents. The present work also showed that MXC 
induces atresia in antral follicles by altering Bcl2 pathways. These results are important as 
interruption of these apoptotic pathways could rescue follicles from MXC-induced atresia and 
thus improve the fertility in the exposed groups. However, future studies are required to develop 
methods to minimize or prevent the toxicity of MXC on fertility. 
 
2.2 Background 
Ovarian Physiology and Atresia  
The ovaries of female mammals contain a fixed number of primordial follicles at the time 
of birth (Hirshfield, 1991; Greenfeld and Flaws, 2004). These primordial follicles grow into 
more mature follicle stages known as primary, pre-antral, and antral follicles (Figure 2.2). These 
follicles contain the female germ cell (oocyte) with the somatic cells surrounding it. Follicles are 
classified based on the type and number of layers of somatic cells. The earliest stage of follicle is 
primordial follicle, which contains an oocyte surrounded by a single layer of fusiform granulosa 
cells. Some primordial follicles will grow into the primary stage, which is defined by a slightly 
larger oocyte surrounded by a single layer of cuboidal granulosa cells.  After the primary stage, 
follicles grow into the pre-antral stage, which is characterized by an oocyte surrounded by 2-4 
layers of granulosa cells and a theca cell layer. Pre-antral follicles then grown into antral 
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follicles, which contain an oocyte surrounded by several layers of granulosa cells, a fluid filled 
antral space antrum, and two distinct layers of thecal cells. Antral follicles are the only type of 
follicles capable of releasing fertilizable oocyte and they are the major site of synthesis of steroid 
hormones such as estrogens. The estrogens produced by antral follicles are essential for normal 
menstrual and estrous cyclicity, maintenance of the female reproductive tract, and maintenance 
of non-reproductive tissues such as bones, vascular tissues, and the brain (Hirshfield, 1991; Britt 
and Findlay, 2002; Findlay et al., 2001; Couse and Korach, 1998). 
 During the reproductive lifespan, a constant stream of follicles grows from the primordial 
to the antral stage. Although a few antral follicles ovulate and become fertilized, approximately 
99% of all follicles die via a process known as atresia. Many chemicals are known to affect 
follicular growth and atresia; thus, affecting reproductive function. Chemicals such as MXC are 
of concern because they increase the rate of atresia of follicles. In turn, this leads to acceleration 
in the rate of depletion of follicles, resulting in an early menopause or early reproductive 
senescence. Early menopause is a concern because it has been associated with an increased risk 
of chronic diseases such as osteoporosis and cardiovascular disease (Sowers and La Pietra, 
1995).   
 
MXC 
Biochemistry of Methoxychlor 
 
The structure of MXC is shown in figure 2.1.  The oral lethal dose50 (LD50) of MXC in 
rat is >6000 mg/kg, making this chemical less acutely toxic than DDT, which has an oral LD50 of 
118 mg/kg (ATSDR, 2002). Animal studies suggest that MXC is converted to more soluble 
metabolites in the liver.  MXC and its metabolites are excreted mainly through feces and to a 
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lesser extent in urine within 24 h of ingestion (Kapoor et al., 1970). In livers of rats and humans, 
1,1,1-trichloro-2,2-bis(4-methoxyphenyl)ethane (methoxychlor; MXC)  converts to mono- and 
the bis-demethylated metabolites: 1,1,1-trichloro-2(4-methoxyphenyl),2(4-hydroxyphenyl)ethane 
(mono-OH-MXC) and 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane (HPTE) (Stresser and 
Kupfer, 1998; Kapoor et al., 1970). CYP1A2 and CYP2C19 are involved in demethylation of 
MXC, forming mono- and bis-demethylated metabolites in tissues (Stresser and Kupfer, 1998).  
Further, the mono- and bis-demethylated metabolites are metabolized to the more polar ring 
hydroxylated metabolite tris-OH-MXC by CYP3A4 enzymes (Stresser and Kupfer, 1997, 1998; 
Kupfer et al., 1990).  
I focused my project on MXC for several reasons.  First, MXC is widely used in many 
countries against insects that attack fruits, vegetables, and home gardens. MXC has been found 
in 1.2% composite food samples in the US (Badach et al., 2000, Badach et al. 2007). One study 
in Poland showed that the MXC concentration in water reached up to 0.31 g/l (Buczynska and 
Szadkowska-Stannczyk, 2005). A study in Connecticut showed that up to 35% of agricultural 
commodities contain pesticide residues and that MXC is present in lettuce, strawberries, spinach, 
and peas (Krol et al., 2000). When it is aerially sprayed, MXC contaminates wide areas 
including water bodies and it travels to distant areas through wind or running water. Thus, air, 
water or foods are the main sources of MXC exposures for human beings and other species. Due 
to failure of manufacturer registration with the Environmental Protection Agency (EPA), MXC 
production has been stopped in the US (Mulkey, 2002). However, MXC is still used in many 
countries for agricultural products that are imported in to the US, resulting in human exposure in 
the US. Further, MXC persists in soil, and residues are present even after 18 months of post 
treatment of microbes that scavenge MXC (Golovleva et al., 1984). 
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 Second, humans are exposed to MXC through food and water consumption (Campoy et 
al., 2001). The half life of MXC is 24 h and most of its metabolites leave the body primarily 
through feces and secondarily through urine. The EPA limits the amount of  MXC present in 
drinking water to be 0.04 parts of MXC per million parts of water (ppm) and it has also set the 
limits in agricultural products (crops, fruits, vegetables, grains, meats, milk, and food for 
livestock) to be 1-100 ppm (ATSDR, 2002). An FDA survey has indicated that the average 
intake of MXC in foods is 0.8 g/day or about 292 g/year. People working in manufacturing 
industries and who live near farms have great chances of high exposure to MXC. Occupational 
exposure to MXC in farm people has been measured to be 5.16 g/ml in serum (ATSDR, 2002). 
Once MXC enters the body, it reaches serum, placenta, breast milk, and adipose tissue. One 
study has shown that the levels of MXC can reach 0.39 ng/ml in serum and 155.58 g/kg in 
adipose tissue (Botella et al., 2004). Many studies have shown that the concentration of MXC 
can reach 10.41g/kg in placenta (Lopez-Espinosa et al., 2007), 1.01 ng/ml in breast milk, 2.49 
ng/ml in transition milk, and 18.1 ng/ml in colostrum (Campoy et al., 2001). Further, one study 
has detected several pesticide residues including MXC in milk and it also found an association 
between breast milk exposure of organochlorine pesticides and cryptorchidism (Damgaard et al., 
2006).  
Third, I selected MXC for the study because it is known to be a female reproductive 
toxicant (Eroschenko and Cooke, 1990; Symonds et al., 2006; Borgeest et al., 2004). Several 
studies have reported that MXC reduces fertility in variety of species (Gupta et al., 2007; 
Cummings and Gray, 1989). Studies have shown that MXC is estrogenic in the uterus and anti-
estrogenic in the ovary. In utero exposure to MXC increased atretic follicles in F1a litters and the 
residual effect of MXC induced advanced vaginal opening in F1b litters. In addition, mothers 
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exposed to MXC have an increased gestation period and increased number of dead fetuses 
compared to vehicle controls during the first pregnancy (Swartz and Corkern, 1992).  In sheep, 
prenatal exposure to MXC delays the luteinizing hormone surge in offspring, suggesting that 
MXC exposure has long-term endocrine effects that control fertility (Savabieasfahani et al., 
2006). Neonatal exposure to MXC in mice caused no problems with mating, but decreased 
ovulation and pregnancy rate. In addition, MXC also decreased the number of live fetuses and 
increased resorbed fetuses (Swartz and Eroschenko, 1998). In another study, neonatal exposure 
to high doses of MXC (67.6 and 135.1 mg/kg/d) in female mice also induced ovarian atrophy, 
decreased relative ovarian weight, and decreased corpora lutea (CL) numbers, whereas exposure 
to low doses of MXC (6.8 and 13.5 mg/kg/d) showed opposite effects, and the ovaries contained 
large, heavy, and increased CL numbers (Eroschenko et al., 1995, Eroschenko et al., 1997). 
Further, MXC exposure on day 1 through 4 of pregnancy inhibits implantation in mice. In 
addition, it also affects uterine receptivity and embryonic development and transport, suggesting 
estrogenic action of MXC at the level of the uterus and oviduct (Hall et al., 1997). In adult 
female mice, MXC induces persistent vaginal estrus, decreases ovarian weight, and increases the 
number of atretic large follicles compared to vehicle controls (Martinez and Swartz, 1992). 
Specifically, MXC has been shown to target antral follicles, reducing the number of healthy 
antral follicles and increasing the atresia of follicles.  MXC-induced atresia of antral follicles 
involves Bcl2 and oxidative stress pathways and it has been shown to inhibit antral follicle 
growth in vitro (Borgeest et al., 2002, Borgeest et al., 2004; Gupta et al., 2006; Miller et al., 
2005).  
Previous studies have demonstrated various effects of MXC on male reproductive 
functions. Exposure to MXC in male rats from weaning through adulthood exhibited delayed 
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puberty, decreased epididymal weight, and decreased number of sperm in the ejaculate, without 
change in sperm number in testis (Gray et al., 1989). Fetal exposure to low doses of MXC 
increased the prostate size in adult mice (Welshons et al., 1999). Also, exposure to MXC 
reduced seminal vesicle weight, serum testosterone, dehydroepiandrosterone levels and increased 
follicle-stimulating hormone levels (Murono et al., 2006). Perinatal and juvenile exposure to 
MXC reduced testicular weight, number of epididymal spermatozoa, and sertoli cell numbers 
(Larry et al., 2002).  
MXC has been shown to alter oxidative stress and cell cycle regulators in the ovary.  
MXC increases H2O2, reactive oxygen species (ROS), and also decreases mRNA expression and 
activity of antioxidants such as Cu/Zn superoxide dismutase (SOD1), glutathione peroxidase 
(GPX), and catalase (CAT) in the mouse ovary. Collectively, these studies suggest that MXC 
induces apoptosis in the ovary by inducing the oxidative stress disrupting the mitochondrial 
homeostasis (Gupta et al., 2006a). Exposure to MXC in vivo and in vitro reduces expression of 
cell cycle regulators: PCNA protein and Ccnd2 and Cdk4 in ovarian tissues (Gupta et al., 2009). 
In addition, treatment with the anti-oxidant N-acetyl cysteine increases Ccnd2 and Cdk4 levels in 
MXC-treated antral follicles, suggesting that MXC-induced oxidative stress decreases the levels 
of cell cycle regulators, which in turn, results in inhibition of the growth of antral follicles (Gupta 
et al., 2009; Gupta et al., 2006b). 
 Fourth, I elected to study MXC because it is considered to be a model endocrine disruptor 
and environmental estrogen (Cummings, 1997). MXC is considered to have estrogenic as well as 
anti-estrogenic activities depending on the species and tissue type (Ostby et al., 1999; Gray et 
al., 1988; Hall et al., 1997). These endocrine disrupting activities have been suspected to be the 
reason that MXC causes infertility. Thus, studying the model endocrine disruptor MXC will be 
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useful for identifying the mechanisms by which environmental estrogenic and anti-estrogenic 
compounds affect ovarian function and/or fertility.  
 A final reason for focusing on MXC is that many wild-life species have been exposed to 
MXC and are at great risk of reproductive damage. One study has found MXC and other 
organochlorine residues in finfish in Maryland waters (Eisenberg and Topping, 1985). Another 
study on Michigan Rivers has found MXC in fish (Giesy et al., 1994).  Further, many studies 
have found MXC in crocodiles from Costa Rica and Belize, in elephant seals in Antarctica, and 
in Arctic beluga whales (Rainwater et al., 2007; Wu et al., 2006; Miranda-Filho et al., 2007; 
Stern et al., 2005). Thus, by understanding the mechanism of MXC action, it may be possible to 
determine the potential impacts of environmental chemicals on wide variety of species.  
 
MXC and Estrogen levels  
 Estrogens are important in maintaining physiology of a vast number of tissues, including 
reproductive tissues. Estrogens are involved in the maintenance of the estrous cycle, growth of 
follicles, ovulation, fertility, and maintenance of pregnancy. Estradiol (E2) is the principal 
estrogen formed in the body and is synthesized from cholesterol. In theca cells, cholesterol is 
transported from the outer region to inner portion of mitochondria by steroid acute regulatory 
protein (StAR) protein and is converted to pregnenolone by CYP450 side chain cleavage enzyme 
(CYP450scc). Then two enzymatic pathways convert pregnenolone to androstendione. In one 
pathway, 3β-hydroxysteroid dehydrogenase (3β-HSD) catalyzes the conversion of pregnenolone 
to progesterone. The progesterone is then converted to androstenedione via 17α-hydroxylation of 
progesterone by 17α hydroxylase and 17, 20 lyase (CYP17α). In the second pathway, 
pregnenolone is converted to 17α-hydroxypregnenolone and then to dihydroepiandrosterone 
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(DHEA) by CYP17α. The DHEA is then finally converted to androstenedione by 3βHSD. 
Androstenedione is converted to testosterone by 17β-hydroxysteroid dehydrogenase. Further, 
testosterone is transferred to granulosa cells where it is converted to estrogens by aromatase 
enzyme (CYP19). The estrogens are then released into the blood stream to carry out a variety of 
functions in the body (Suter, 2004) (Figure 2.3). 
Many previous studies have shown that several environmental toxicants are involved in 
alteration of E2 levels. Previous studies have shown that bisphenol A decreases E2 levels 
including other intermediates of the E2 steroidogenic pathway in the ovarian antral follicles 
(Peretz et al., 2011). Studies have shown that di-(2-ethylhexyl) phthalate and mono-(2-
ethylhexyl) phthalate reduce E2 levels in antral follicles and granulosa cells of the ovary (Gupta 
et al., 2010; Lovekamp and Davis, 2001). Exposure to cigarette smoke also has been associated 
with decreased E2, estrone and estriol levels in humans (Soldin et al., 2011). Importantly, studies 
have shown that exposure to MXC and its metabolites causes reduction in E2 levels. Studies in 
rat has shown that MXC does not alter E2 levels in serum, but decreases E2 levels  in ovarian 
culture (Cummings and Laskey, 1993) and studies on bovine granulosa cells also have shown 
that MXC (1 μg/ml) decreases E2 levels (Tiemann et al., 1996). Mono-hydroxy MXC a 
metabolite of MXC has also been shown to decrease E2 levels in antral follicles of the ovary 
(Craig et al., 2010). 
 Our data indicated that MXC reduces E2 levels in antral follicles in vitro. Based on such 
data, my hypothesis was that MXC reduces estradiol levels either by alteration of CYP 450 
enzymes involved in E2 biosynthesis pathway or up-regulation of CYP450s involved in E2 
metabolism. Thus, the present work examined both E2 biosynthesis and metabolism.  
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MXC and the Apoptotic Pathway 
Apoptosis or programmed cell death is a normal physiological process that occurs in all 
multicellular organisms to remove cells that are superfluous, have already completed their 
specific functions, or are harmful to the whole organism (Thompson, 1995; Kerr et al., 1972). 
During reproductive life, over 99% of ovarian follicles undergo atresia at the early antral follicle 
stage (Hsu and Hsueh, 1998; Hsueh et al., 1996). The process of atresia occurs via apoptosis. 
Apoptosis of ovarian follicle cells is mainly regulated by pro-survival hormones such as 
gonadotropins, which act on the ovary to produce paracrine and autocrine factors such as 
estrogens, cytokines, interleukin-1, nitric oxide, and insulin-like growth factor I.  It is likely that 
none of these factors is singularly obligatory in the control of follicle growth or demise. Instead, 
a balance of these different survival and apoptotic factors may decide whether a follicle will 
continue development or undergo apoptosis.  
 Several anti-apoptotic factors Bcl2, Bcl-xL, and Mcl-1 help in cell survival, whereas pro-
apoptotic factors such as Bax, Bak, and Bok antagonize cell survival and induce apoptosis (Hsu 
et al., 1997; Chittenden et al., 1995; Oltvai et al., 1993). In a biological system, it is the ratio of 
Bcl2:Bax that determines the fate of the cell either to death or survival. When Bcl2 is in excess, 
either Bcl2:Bax heterodimers or Bcl2 homodimers predominate and the cells are protected. 
When Bax is in excess, Bcl2:Bax heterodimers or Bax homodimers predominate and the cells are 
prone for apoptosis (Basu and Haldar, 1998). In Bcl2 overexpressors, there is a suppression of 
follicular cell apoptosis and enhancement of folliculogenesis, suggesting involvement of the Bcl2 
system in the ovary (Hsu et al., 1996). In addition, in mice with elevated Bcl2, there is a 
suppression of apoptosis, which is induced by external agents both in vivo and in vitro (Baffy et 
al., 1993; Allsopp et al., 1993; Nunez et al., 1991).  Mice deficient in Bcl2 do not show any 
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abnormality during development, but only few tissues including hair follicles, lymphoid systems, 
and kidney show apoptosis (Veis et al., 1993; Sorenson et al., 1995). In addition to Bcl2, several 
other proteins such as Bcl-xL, Mcl-1, and Bfl-1 have similar anti-apoptotic activity by 
interacting with Apaf-1, preventing activation of caspases, thus, suppressing the caspase cascade 
and apoptosis (Hsu and Hsueh, 2000). Expression of Bcl-xL can lead to significant resistance to 
apoptosis at least as much as Bcl2 (Boise et al., 1993).  The importance of Bax was explained by 
increase in number of primordial follicles in Bax deleted mice (Perez et al., 1999).  Another pro-
apoptotic factor Bok preferentially dimerizes with Mcl-1, Bfl-1, but not with Bcl-2, Bcl-w, and 
Bcl-xL (Inohara et al., 1998).  Survival factors such as gonadotropins increase the 
phosphorylation of BAD; thus, dampening its killing ability (Del Peso et al., 1997; Zha et al., 
1996). The pro-apoptotic factors such as Bax, Bak, and Bok dimerize with anti-apoptotic 
proteins, relieving the Bcl2 suppressed Apaf-1 and altering the membrane homeostasis, thus 
increasing cytochrome c release inducing the caspase cascade and apoptosis. The released 
cytochrome c binds to Apaf-1 and procaspase-9 to form active apoptosome complex. Activated 
caspase-9, in turn cleaves and activates caspase-3 and other caspases. These activated caspases in 
turn increase the mitochondrial permeability by converting the anti-apoptotic factors into pro-
apoptotic factors and ligands. Finally, activated caspases cleave several proteins and DNA 
leading to formation of apoptotic bodies (Hsu and Hsueh, 2000). 
 In addition to being important regulators of natural atresia, Bax and Bcl2 are involved in 
chemical induction of apoptosis. The industrial chemical, 4-vinylcyclohexene diepoxide (VCD) 
has been shown to induce atresia in small pre-antral follicles by altering Bcl2 family members 
(Hu et al., 2001). The polyaromatic hydrocarbon dimethylbenz(a)anthracene also has been 
shown to increase Bax levels, inducing apoptosis in mouse oocytes (Matikainen et al., 2001). 
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Further, chromium has been shown to increase Bax and decrease Bcl2, inducing apoptosis in 
mouse ovarian granulosa cells (Banu et al., 2011). Importantly, studies involving in vivo and in 
vitro MXC exposure showed that apoptosis was increased, with an increase of Bax and with no 
alteration or decrease in Bcl2 levels (Miller et al., 2005; Borgeest et al., 2002). 
 The importance of pro-apoptotic and anti-apoptotic factors in chemical induction atresia, 
made us to examine these factors in response to MXC. Thus, our study examined and found that 
MXC alters Bcl2 and Bax factors and increase caspase activities, which further induce atresia in 
antral follicles.  
 
Methoxychlor and the Aryl Hydrocarbon Receptor Pathway 
 These studies focused on whether MXC mediates toxicity via AHR. The AHR is a ligand 
activated transcription factor present in the cytoplasm of cells, which exists as a complex with 
heat shock protein 90, immunophilin like protein XAP2, and co-chaperone p23.  Once ligand 
binds to the AHR complex, it translocates into the nucleus, where the ligand-AHR is released 
from the complex and heterodimerizes with the aryl hydrocarbon nuclear translocator (ARNT). 
The newly formed ligand-AHR-ARNT complex then binds to AHR response elements adjacent 
to target promoters of various genes and initiates transcription. There are numerous studies 
showing that activation of the AHR complex initiates transcription of various cytochrome P450 
family of genes such as Cyp1a1, Cyp1a2, and Cyp1b1, which are involved in metabolism of 
various xenobiotics (Hernandez-Ochoa et al., 2009; Whitlock, 1999; Safe, 1995). 
The present study determined whether MXC works through the AHR pathway. The AHR 
pathway was selected for several reasons. First, many studies have demonstrated cross-talk 
between AHR-ER pathways in many tissues (Buchanan et al., 2000; Safe et al., 1998; Wormke 
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et al., 2000). The cross talk between AHR-ER pathways may alter the ability of MXC to reduce 
estradiol levels, induce inhibitory factors, and/or degrade receptors during the process of antral 
follicle toxicity.  
 Second, many environmental toxicants belonging to a group of polyhalogenated aromatic 
hydrocarbons (PAHs) such as the polychlorinated biphenyls (PCBs), polychlorinated dibenzo-p-
dioxins, and polychlorinated dibenzofurans that have been shown to bind to the AHR (Schmidt 
and Bradfield, 1996). Poland and co-workers were the first to show that 2,3,7,8-
tetrachlorodibenzo-p-dioxin (TCDD) binds to AHR in hepatic cytosols (Poland et al., 1976). 
Many other studies have shown that PAHs such as benzo(a)pyrene, 7,12-
dimethybenz(a)nthracene, and 3-methyl cholanthrene decrease the number of primordial and 
primary follicles at birth. Their effects were reduced by treatment with the AHR antagonist -
napthoflavone (ANF), thus, suggesting that these PAHs bind to AHR (Shiromizu and Mattison, 
1984, Shiromizu and Mattison, 1985). Studies have also shown that AHR disruption by ANF 
reduces the ability of 9,10-dimethylbenz(a)antracene-3,4-dihydrodiol (DMBA-DHD) to cause 
cell death and as a result increases the number of fetal oocytes (Matikainen et al., 2002; 
Matikainen et al., 2001). Studies in granulosa cells also have shown that TCDD induces Cyp1a1 
and Cyp1b1 by increasing expression of Ahr (Dasmahapatra et al., 2001). Binding of toxicants to 
the AHR induces metabolic enzymes, leading to a variety of toxic effects. MXC is similar in 
structure to many known AHR ligands.  Thus, it is possible that MXC may bind to the AHR.  
 Third, one study suggests that the AHR mediates the toxicity of MXC in liver cells (Han 
et al., 2007). Han et al. have shown that TCDD induces CYP1A1 expression in mouse liver cells. 
TCDD is the classical ligand known to bind to the AHR and then to induce CYP1A1 expression. 
MXC alone did not block CYP1A1 expression, but when used with TCDD, MXC inhibited the 
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expression of CYP1A1 by blocking the binding potency of the AHR to the dioxin response 
element (DRE) present upstream of CYP1A1 gene. Thus, this raises the possibility of action of 
MXC through the AHR.  Our study shows that MXC binds to AHR, inhibiting follicle growth 
and inducing atresia in mouse ovarian antral follicles. 
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2.3 Figures and Legends 
Figure 2.1 Structure of MXC 
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Figure 2.2 Stages of Follicular Development in the Mammalian Ovary.  
 
 
 
 
1=Oocyte, 2= Granulosa cell layer, 3= Theca cell layer, 4= Antrum 
 
The ovary is composed of different stages of follicles. The earliest stage of the follicles is the 
primordial follicle followed by the primary and pre-antral follicle and finally, the antral follicle. 
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Figure 2.3 Schematic of the Estradiol Bio-synthesis Pathway in the Ovary 
 
 
 
 
 
In thecal cells, cholesterol is converted to androgens: androstenedione and testosterone; Then 
these androgens transported to granulosa cells, where they are converted to estrone and estradiol.  
Both thecal cells and granulosa cells are integral part of isolated follicles used in our 
experiments. 
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CHAPTER III 
 
Methoxychlor reduces estradiol levels by altering steroidogenesis and metabolism in mouse 
antral follicles in vitro 
 
3.1 Abstract 
The organochlorine pesticide methoxychlor (MXC) is a known endocrine disruptor that 
affects adult rodent females by causing reduced fertility, persistent estrus, and ovarian atrophy. 
Since MXC is also known to target antral follicles, the major producer of sex steroids in the 
ovary, the present study was designed to test the hypothesis that MXC decreases estradiol (E2) 
levels by altering steroidogenic and metabolic enzymes in the antral follicles. To test this 
hypothesis, antral follicles were isolated from CD-1 mouse ovaries and cultured with either 
vehicle (dimethylsulfoxide; DMSO) or MXC. Follicle growth was measured every 24 h for 96 h. 
In addition, sex steroid hormone levels were measured using enzyme-linked immunosorbent 
assays (ELISA) and mRNA expression levels of steroidogenic enzymes as well as the E2 
metabolic enzyme Cyp1b1 were measured using qPCR. The results indicate that MXC decreased 
E2, testosterone, androstenedione, and progesterone (P4) levels compared to DMSO. In addition, 
MXC decreased expression of aromatase (Cyp19a1), 17β-hydroxysteroid dehydrogenase 1 
(Hsd17b1), 17α-hydroxylase/17,20-lyase (Cyp17a1), 3β hydroxysteroid dehydrogenase 1 
(Hsd3b1), cholesterol side-chain cleavage (Cyp11a1), steroid acute regulatory protein (Star), and 
increased expression of Cyp1b1 enzyme levels. Thus, these data suggest that MXC decreases 
steroidogenic enzyme levels, increases metabolic enzyme expression and this in turn leads to 
decreased sex steroid hormone levels.  
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3.2 Introduction 
Many chemicals are known to be present in the environment. Many of them mimic 
endocrine hormone functions in the body, interfering with normal endocrine activity in humans, 
wild-life, or laboratory animals, thus, acting as endocrine disrupting chemicals (EDCs) (Crisp et 
al., 1998). The EDC methoxychlor (MXC) is a chlorinated organic pesticide, which is primarily 
used against various species of insects that attack field crops, trees, vegetables, fruits, gardens, 
stored grain, livestock and domestic pets (ATSDR, 2002). This chemical was first registered for 
use in 1948 and was widely used as a replacement for dichlorodiphenyltrichloroethane (DDT) 
until 2004 (Stuchal et al., 2006). MXC is still being used in many countries on agricultural 
products that are imported to the United States (US), resulting in human exposure in the US. 
Further, MXC is persistent in soil and its residues are present even after 18 months of post-
treatment with microbes that scavenge MXC (Golovleva et al., 1984).  
MXC targets the ovary and its exposure has adverse effects on reproductive function in 
adult female mice causing persistent estrus, reduced fertility, ovarian atrophy, and increased 
follicular atresia (Eroschenko et al., 1997; Martinez and Swartz, 1991). Exposure of pregnant 
mice to MXC results in an increased percentage of atretic follicles in female pups compared to 
controls. Further, the next generation of female pups born to the same mother display residual 
effects of MXC, showing accelerated vaginal opening (Swartz and Corkern, 1992). Exposure of 
adult mice to MXC increases lipid accumulation in the interstitial tissue and thecal cells of the 
ovary, mimicking estrogen effects (Martinez and Swartz, 1992). Further, MXC increases the 
number of pyknotic bodies in mouse granulosa cells, decreases the number of healthy antral 
follicles, increases the number of atretic follicles, and increases ovarian surface epithelium height 
(Borgeest et al., 2002; Swartz and Corkern, 1992). Under in vitro conditions, treatment of antral 
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follicles with MXC decreases antral follicle growth and increases atresia (Gupta et al., 2006; 
Miller et al., 2005, 2006).  
The effects of MXC on antral follicles are of concern because antral follicles are the 
structural and functional units of the ovary. Further, antral follicles are the only follicle types that 
have the ability to release eggs for fertilization and to produce sex steroid hormones such as 17β-
estradiol (E2). The E2 produced by antral follicles is essential for normal menstrual and estrous 
cyclicity, maintenance of the female reproductive tract, and maintenance of non-reproductive 
tissues such as bones, vascular tissues, and the brain (Britt and Findlay, 2002; Couse & Korach, 
1998; Findlay et al., 2001).  
E2 production by antral follicles is a complex process in which cholesterol is eventually 
converted to E2. During steroidogenesis, the thecal cells in the follicle acquire cholesterol 
through endocytosis from blood and this cholesterol is stored in the cytoplasm as cholesterol 
esters. Cholesterol has to be transported across both mitochondrial membranes, and this process 
is aided by steroidogenic acute regulatory protein (STAR). The cholesterol side-chain cleavage 
enzyme (CYP11A1) is a rate limiting enzyme present in all the steroidogenic cells. This enzyme 
is attached to the inner mitochondrial membrane and converts cholesterol to pregnenolone.  The 
next enzyme in the steroidogenesis pathway is 3β-hydroxysteroid dehydrogenase (HSD3B1), 
which catalyzes the conversion of pregnenolone to progesterone (P4). Progestins, pregnenolone 
and P4 are converted irreversibly to androstenedione by 17α-hydroxylase/17,20-lyase 
(CYP17A1). Androstenedione is then converted to the more potent androgen testosterone by 
17β-hydroxysteroid dehydrogenase (HSD17B1). This enzyme also catalyzes the conversion of 
estrone to a more potent estrogen, E2. The androgens are then converted to estrogens by 
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aromatase (CYP19A1) (Suter, 2004). E2 then can be metabolized to catecholestrogens (Spink et 
al., 1994).  
Some studies have shown that MXC alters steroidogenesis in isolated granulosa cells and 
whole ovaries, thus acting as an endocrine disruptor (Chedrese and Feyles, 2001; Cummings, 
1997). However, little is known about the effects of MXC on steroid production by antral 
follicles in mice. Therefore, the present study tested the hypothesis that MXC decreases the sex 
steroid hormone levels (E2, testosterone, androstenedione, and P4) produced by antral follicles in 
vitro. The present study also evaluated the mechanism by which MXC alters steroidogenesis by 
examining the effects of MXC on steroidogenic and metabolic enzymes. 
 
3.3 Materials and Methods 
Chemicals: MXC (99% pure) was purchased from Chemservice (West Chester, PA). Stock 
solutions of MXC for in vitro experiments were prepared using dimethylsulfoxide (DMSO) 
(Sigma, St. Louis MO) as a solvent, and in various concentrations (2, 20, and 200 mg/ml) that 
permitted an equal volume of solvent to be added to individual culture wells for each treatment 
group. Thus, final concentrations of MXC in culture were 1, 10, and 100 μg/ml (ppm). The doses 
used in these experiments were selected based on previously published studies showing that 
these concentrations of MXC induce toxicity in antral follicles, granulosa cell culture models, 
and in uterine leiomyoma cells (Chedrese and Feyles, 2001; Gupta et al., 2006; Miller et al., 
2005). These concentrations are relevant to occupational exposure levels. The FDA monitored 
the chemical contaminants in food products in the United States and calculated the average daily 
intake of methoxychlor in adults was up to 4 ng/kg/day (ATSDR, 2002). Normally, serum levels 
were found to be below the level of detection.  However, a study involving an occupational 
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exposure in farm workers has shown that MXC concentration in serum can reach up to 5.16 
µg/mL (ATSDR, 2002). Thus, the occupational exposure dose is much higher than normal 
human exposure and lies between the doses used in the present experiments: MXC 1 µg/ml and 
MXC 10 µg/ml. For controls and MXC treatment groups, DMSO was used at 0.05%, which is 
able to solubilize MXC in aqueous media. DMSO, ITS (insulin, transferrin, selenium), penicillin, 
and streptomycin were obtained from Sigma-Aldrich (St. Louis, MO). Alpha-minimal essential 
media (α-MEM) was obtained from Invitrogen (Carlsbad, CA). Human recombinant follicle 
stimulating hormone (rFSH) was obtained from Dr. A.F. Parlow from the National Hormone and 
Peptide Program (Harbor-UCLA Medical Center, Torrance, CA). Fetal bovine serum (5% FBS) 
was obtained from Atlanta Biologicals (Lawrenceville, GA).  
 
Animals: Adult female cycling CD-1 mice were purchased from Charles River Laboratories 
(Charles River, CA) and housed in the core animal facility located at College of Veterinary 
Medicine, University of Illinois and maintained on 12L:12D cycles. Mice were housed in the 
animal facility for at least two days to relieve transportation stress, given ad libitum food and 
water, and temperature was maintained at 22±1 °C. Animals were euthanized at 35-39 days of 
age by carbon dioxide (CO2) inhalation followed by cervical dislocation. The ovaries were 
removed and antral follicles were isolated as explained below. The University of Illinois 
Institutional Animal Care and Use Committee approved all protocols involving animal care, 
euthanasia, and tissue collection.  
 
Antral follicle culture: Ovaries were removed and antral follicles were isolated from ovaries of 
mice between 35-39 days old because this time point was used in previous studies, and this is the 
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age at which mice are cycling regularly (Borgeest et al., 2004; Miller et al., 2005). Antral 
follicles were isolated mechanically from the ovaries based on relative size and interstitial tissue 
was removed using fine watch maker forceps.  About 3-4 mice were used per experiment and 
they yielded approximately 20-30 follicles per mouse. Once follicles were isolated, they were 
placed individually in wells of a 96-well culture plate with 150 µl of unsupplemented α-MEM 
prior to treatment. Each treatment group in an experiment consisted of 10-15 follicles. 
Supplemented α-MEM was prepared with: 1% ITS (10 ng/ml insulin, 5.5 ng/ml transferrin, 5.5 
ng/ml selenium), 100 U/ml penicillin, 100 mg/ml streptomycin, 5 IU/ml rFSH and 5% FBS. A 
dose response regimen of MXC (1-100 μg/ml) and vehicle controls (DMSO) was individually 
prepared in supplemented α-MEM. For treatment, unsupplemented α-MEM was removed from 
each well and replaced with 150 μl of supplemented α-MEM containing MXC or DMSO. 
Follicles were then incubated for 24, 48, and 96 hours (h) at 37°C in 95% air and 5% CO2. Non-
treated controls (supplemented media alone) were used in each experiment as a control for 
culture conditions. At the end of 24, 48, and 96 h follicle cultures, media were collected and 
stored at -80⁰C for later use. In addition, follicles were collected, snap frozen, and stored at -80⁰C 
for later use.  
 
Analysis of follicle growth: Antral follicles were cultured as described above for 96 h. 
Follicle growth was examined in 24 h intervals by measuring follicle diameters across 
perpendicular axes with an inverted microscope equipped with a calibrated ocular micrometer. 
Antral follicles were considered as those follicles having diameters of 200 µm or greater (Miller 
et al., 2006), which correlates with the histological appearance of antral follicles. At least three 
separate culture experiments were performed for each chemical treatment. In the present study, 
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we first averaged the sizes of follicles in each treatment group within each experiment and then 
data were averaged and analyzed across different experiments (n=3 separate experiments). 
 
Hormone measurements: The media samples from at least 9-12 individual wells distributed 
equally across 3-4 experiments were randomly selected and subjected to enzyme-linked 
immunosorbent assays (ELISA) as described previously (Craig et al., 2010). E2, testosterone, 
androstenedione, and P4 levels were measured in the media using kits from DRG International 
(Mountainside, NJ). These sex steroid hormones were selected since they are the major 
intermediates in the biosynthesis of E2 (Jones and DeCherney, 2005). The sensitivities for each 
kit were 9.714 pg/ml for E2, 0.083 ng/ml for testosterone, 0.019 ng/ml for androstenedione, and 
0.045 ng/ml for P4. The intra-assay coefficients of variation (CVs) were 4.7% for E2, 7.1% for 
testosterone, 10.2% for androstenedione, and 11.4% for P4. The inter-assay CVs were 7.8% for 
E2, 3.6% for testosterone, 6.5% for androstenedione, and 10.4% for P4. The cross reactivity with 
other hormones for each type of kit was negligible.  
 
Quantitative real-time polymerase chain reaction (qPCR): Total RNA was isolated from 
frozen follicles using the RNeasy Micro Kit (Qiagen, Inc., Valencia, CA) following the 
manufacturer’s protocol. RNA was treated with DNAse to remove any possible genomic DNA 
contamination. The concentration of RNA in each sample was measured at 260 nm using the 
Nanodrop ND1000 UV-Vis spectrophotometer (Nanodrop Technologies, Wilmington, DE). The 
cDNA was synthesized by reverse transcribing the mRNA (200 ng) using an iScript cDNA 
synthesis kit (Bio-Rad, Hercules, CA) according to the manufacturer’s instructions. Then cDNA 
was diluted to 1:4 with nuclease free water. 
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qPCR was conducted using CFX96 Real-time System C1000 Thermal Cycler (Bio-Rad). 
All samples were measured in triplicate, and each reaction contained 2 μL of diluted cDNA, 0.66 
μL (330nM) of gene-specific primers (Integrated DNA Technologies, Inc, Coralville, IA, Table 
1), 2.34 μL of nuclease-free water, and 5 μL of SsoFast EvaGreen Supermix (Bio-Rad) for a 
final volume of 10 μL. The qPCR program consisted of an enzyme activation step (95 °C for 1 
min), an amplification and quantification program [40 cycles of 95 °C for 10 sec, 
annealing/extension for 10 sec (Table 1), single fluorescence reading], a 72 °C for 5 min step, a 
melt curve (65 - 95°C heating 0.5 °C per second with continuous fluorescence readings) and a 
final step at 72 °C for 5 min.  
Primer sequences are shown in Table 1. The specificity of each primer was tested using 
BLASTN2.218+ and by the presence of a single peak in the melt curve analysis. In addition, 
each product was run on 2% agarose gels to confirm the product size. A standard curve was 
generated from six serial dilutions of one of the samples (1:2, 1:4, 1:8, 1:16, 1:32, and 1:64); 
thus, allowing analysis of the amount of cDNA in the exponential phase. β-Actin was used as a 
reference gene. Final values were expressed as genomic equivalents and were calculated as the 
ratio of each gene to β-actin. The reported data were obtained from the mean expression values 
of 3-4 separate culture experiments. 
 
Statistical analysis: All data were analyzed using SPSS statistical software (SPSS Inc., Chicago, 
IL). For all comparisons, statistical significance was assigned at p ≤ 0.05. Comparisons between 
DMSO and the different doses of MXC were conducted on data obtained from 3 to 4 
experiments using one-way analysis of variance (ANOVA) followed by Tukey's post hoc test or 
a test for linear regression when applicable. 
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3.4 Results 
Effect of MXC on steroid hormone levels 
 Previous studies have shown that MXC inhibits growth of mouse antral follicles after 96 
h of in vitro culture (Gupta et al., 2006; Miller et al., 2005). In the present study, we confirmed 
these previous findings and showed that MXC inhibits follicle growth at 48, 72, and 96 h (Figure 
3.1). We further investigated whether MXC alters E2 levels. At 24h, MXC did not alter E2 levels. 
However, at 48 (MXC 1, 10 and 100 µg/ml) and 96 h (MXC 10 and 100 µg/ml), MXC exposure 
significantly decreased E2 levels compared to vehicle control (DMSO) (Figure 3.2). 
In addition to E2 levels, we also investigated whether MXC affected biosynthetic 
hormone precursors of E2 such as testosterone, androstenedione, and P4. MXC did not affect 
testosterone levels at 24 and 48 h, but it decreased the levels at 96 h (MXC 10 and 100 µg/ml) 
compared to controls (Figure 3.3). MXC did not affect androstenedione levels at 24 h, but it 
decreased the levels at 48 (MXC 1, 10, and 100 µg/ml) and 96 h (MXC 1, 10, and 100 µg/ml) 
compared to controls (Figure 3.4). MXC did not alter P4 levels significantly at any time point, 
however, the test for linearity using regression analysis showed that P4 levels trended downwards 
at 96 h compared to DMSO controls (p=0.065) (Figure 3.5). 
 
Effect of MXC on expression of enzymes that synthesize ovarian steroids 
 Since MXC decreased levels of steroid hormone precursors and E2 levels, we next 
examined whether the decreased steroidogenesis could be due to effects of MXC on mRNA 
expression of steroidogenic enzymes. We focused on expression levels because previous studies 
have shown that the activities of enzymes are directly related to their transcriptional regulation 
(Jones and DeCherney, 2005; Miller, 1989).  
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MXC significantly affected expression of Cyp19a1 levels, the enzyme that converts 
testosterone to E2 (Fig. 6). At 24 h (MXC 1 µg/ml), MXC significantly increased expression of 
Cyp19a1 enzyme levels compared to DMSO. However, at 48 (MXC 100 µg/ml) and 96 h (MXC 
10 and 100 µg/ml), MXC significantly decreased expression of Cyp19a1 compared to DMSO. In 
the MXC 1 µg/ml treatment group, the enzyme levels were significantly decreased at 48 and 96 h 
compared to 24 h (Figure 3.6).  
MXC significantly decreased levels of Hsd17b1, the enzyme that converts 
androstenedione to testosterone (Fig. 7). In the MXC 100 µg/ml treatment groups, Hsd17b1 
expression levels were significantly decreased at 24, 48, and 96 h compared to DMSO groups. In 
the MXC 1 µg/ml group, the Hsd17b1 enzyme levels were significantly decreased at 96 h 
compared to 24 h (Figure 3.7). 
MXC also significantly decreased Cyp17a1 levels, the enzyme that converts P4 to 
androstenedione (Fig. 8). These enzyme expression levels were significantly decreased at 48 h 
(MXC 10 and 100 µg/ml) and showed a significantly decreased trend at 96 h compared to 
DMSO. The levels in the MXC 10 µg/ml group were significantly decreased at the 48 and 96 h 
time points compared to 24 h (Figure 3.8).   
MXC significantly decreased Hsd3b1 levels, the enzyme that converts pregnenolone to P4 
and dehydroepiandrosterone to androstenedione (Fig. 9). Hsd3b1 expression levels were 
significantly decreased as early as 24 h (MXC 100 µg/ml) and continued to be decreased at 48 
(MXC 100 µg/ml) and 96 h (MXC 10 and 100 µg/ml) compared to DMSO groups. In the MXC 
10 µg/ml treatment group, Hsd3b1 expression levels were significantly different across different 
time points. The levels were significantly decreased at 48 and 96 h compared to 24 h. In the 
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MXC 100 µg/ml treatment group, Hsd3b1 expression levels were significantly decreased at 48 h 
compared to 24 h (Figure 3.9). 
MXC significantly decreased Cyp11a1 expression levels, the mitochondrial enzyme that 
converts cholesterol to pregnenolone (Fig. 10). Cyp11a1 expression levels were significantly 
decreased at 48 (MXC 100 µg/ml) and 96 h (MXC 10 and 100 µg/ml) compared to DMSO 
groups. There were no differences between expression levels in each treatment group when 
compared across different points (Figure 3.10).  
MXC significantly decreased Star expression levels, the enzyme that is involved in the 
transport of cholesterol from the cytoplasm into mitochondria during steroidogenesis in the theca 
cells (Fig. 11). When treatment groups were compared within each time point, Star expression 
levels were significantly increased at 48 h (MXC 100 µg/ml) and significantly decreased at 96 h 
with MXC 10 µg/ml (p=0.01) and trended toward decreased expression with MXC 100 µg/ml 
(p=0.065) compared to DMSO. When the expression levels of each treatment group were 
compared across the different time points, Star expression levels in DMSO and MXC 1 µg/ml 
treatment groups were increased at 96 h compared to 24 h (Figure 3.11).  
  
Effect of MXC on expression of an enzyme that metabolize E2 
MXC significantly altered expression of Cyp1b1 levels, the enzyme that converts E2 to 
catecholestrogen. Specifically, MXC (100 µg/ml) significantly reduced expression of Cyp1b1  
levels by 24 h and did not affect the levels at 48 h, but significantly induced expression levels by 
96 h compared to DMSO controls (Figure 3.12). In the MXC 10 µg/ml treatment group, 
expression levels were increased at 48 h compared to 24 h and in the MXC 100 µg/ml treatment 
group, expression levels were increased at 96 h compared to 24 h. The ability of MXC to 
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increase expression of Cyp1b1 at 96 h was similar to that of 2,3,7,8-tetrachlorodibenzo-p-dioxin 
(TCDD: 10nM), a known inducer of Cyp1b1 expression (Dasmahapatra et al., 2001).  
 
3.5 Discussion 
The present studies were designed to test the hypothesis that MXC decreases E2 levels 
produced by antral follicles by altering steroidogenic and metabolic enzymes. This study 
confirms results from previous studies that MXC inhibits follicle growth in cultured mouse antral 
follicles (Gupta et al., 2006; Miller et al., 2005). This study also expands previous studies by 
examining the effects of MXC on the steroidogenesis pathway. In the current study, MXC 
decreased follicle growth, hormone levels, and most enzyme mRNA levels as early as 48 h. 
However, MXC decreased Hsd17b1 and Hsd3b1 expression levels as early as 24 h. Thus, this 
study shows that some of the earliest induced changes by MXC may be in some steroidogenic 
enzymes. These early changes in Hsd17b1 and Hsd3b1 may lead to the decrease in hormone 
levels observed in MXC-treated follicles. Further, since adequate levels of sex steroids are 
required for follicle growth (Drummond et al., 2006), the changes in hormones may contribute to 
MXC-induced inhibition of follicle growth. 
Our data showed that MXC decreases E2 levels in cultured mouse antral follicles. These 
results are consistent with previous findings performed in rat ovarian culture studies (Cummings 
and Laskey, 1993) and studies on bovine granulosa cells showing that MXC (1 μg/ml) decreases 
E2 levels (Tiemann et al., 1996). However, the present study demonstrates that MXC disrupts E2 
produced by intact mouse antral follicles and expands previous studies by showing that MXC 
disrupts steroid precursors made in both thecal and granulosa cells of the follicle. The data 
obtained using intact antral follicles are significant since antral follicles are the functional units 
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of the ovary that produce sex steroid hormones, which are involved in various important 
physiological functions in the body, including ovulation. 
The present studies also showed that MXC inhibits testosterone production and causes a 
decreased trend in P4 levels in cultured mouse antral follicles. These data are consistent with 
previous studies in rat ovarian cultures showing that MXC decreases testosterone, but not P4 
levels in the media (Cummings and Laskey, 1993) and that MXC decreases P4 levels in vivo 
(Chapin et al., 1997). Our data on P4 levels are also similar to data from studies on porcine 
granulosa cells showing that MXC decreases P4 levels (Chedrese and Feyles, 2001). In addition, 
another study in cultured bovine granulosa cells showed that MXC decreases P4 synthesis 
(Tiemann et al., 1996). Other studies have also shown that MXC decreases testosterone levels in 
male rat testes in vivo (Murono et al., 2006). Thus, our data in conjunction with others from rat, 
porcine, and bovine studies suggest that MXC may have similar effects on steroidogenesis across 
various tissues and species. The present study also expands previous studies by measuring 
another steroid hormone - androstenedione, which also is significantly decreased in response to 
MXC. Thus, suggesting that in addition to E2, testosterone, and P4, MXC has significant negative 
effects on androstenedione levels. 
 Some of the effects of MXC on steroid levels are similar to those produced by 
metabolites of MXC. Previous studies in liver cells have shown that MXC is metabolized to 
metabolites such as 2-(p-hydroxyphenyl)-2-(p-methoxyphenyl)-1,1,1-trichloroethane (mono-OH 
MXC) and 2,2-bis-(p-hydroxyphenyl)-1,1,1-trichloroethane (HPTE) (Kapoor et al., 1970) by 
cytochrome P450 (Cyp) enzymes Cyp1a2 and Cyp2c29 (Stresser and Kupfer, 1998). These Cyp 
enzymes are expressed in the ovary and can be altered by MXC treatment (Paulose et al., 2011; 
Symonds et al., 2006). Thus, the ovary is equipped with Cyp enzymes to metabolize MXC to 
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mono-OH MXC and HPTE.  Mono-OH MXC has been shown to decrease E2, androgen, and P4 
levels by altering the expression of steroidogenic enzymes in the antral follicles from mouse 
ovaries (Craig et al., 2010) and HPTE been shown to inhibit P4 and E2 production in rat theca-
interstitial and granulosa cultures by inhibiting steroidogenic enzymes (Akgul et al., 2008; 
Zachow and Uzumcu, 2006). This raises the possibility that the effects of MXC on steroid levels 
observed in this study are due to MXC metabolites and not just MXC alone. It is possible that 
ovarian follicles have the capacity to convert MXC to mono-OH MXC and/or HPTE and that 
these metabolites inhibit steroid hormone levels. Alternatively, it is possible that the ovarian 
follicles do not convert MXC to its metabolites and that MXC itself can inhibit steroid levels. 
Future studies should distinguish between these possibilities. 
Since we observed alterations in hormone levels in response to MXC, we investigated the 
mechanism by which MXC alters hormone levels by measuring steroidogenic and metabolic 
enzymes and found that MXC does indeed decrease steroidogenic enzymes and increase the 
metabolic enzyme, Cyp1b1. Some of the changes in metabolic enzymes may explain our data on 
follicle growth and steroid levels. At 48 h, MXC 1 µg/ml inhibits E2 levels, but these levels 
return to normal at 96 h. MXC also increases expression of Cyp19a1 at 24 h. Thus, we speculate 
that MXC increases Cyp19a1 protein and activity and that this in turn leads to an increase in 
conversion of testosterone to E2, which restores E2 levels. Because E2 is important for follicle 
growth, the normal E2 levels could then restore follicle growth at the 1 µg/ml of MXC.  
While there are limited other data on the effects of MXC on steroidogenic enzymes, a 
few studies have shown that metabolites of MXC may affect steroidogenic enzymes in other 
tissues and culture systems. Studies in rat granulosa cells showed that the MXC metabolite, 
HPTE (10 µM; 48 h), blocks FSH-stimulated mRNA expression levels of Cyp19a1 and that 
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these levels remain suppressed in the presence of dibutyryl-cAMP (db-cAMP) (Zachow and 
Uzumcu, 2006). Another metabolite of MXC, mono-OH MXC, also inhibits Cyp19a1 mRNA 
expression levels in mouse antral follicles (Craig et al., 2010). Studies in human and rat testes 
indicate that MXC and HPTE decrease HSD17B1 activity (Hu et al., 2010; Vaithinathan et al., 
2008) and studies in mouse antral follicles show that mono-OH MXC decreases expression of 
Cyp17a1 levels (Craig et al., 2010). The previous studies have shown that MXC and its 
metabolite HPTE inhibit HSD3B1 activity in human and rat testes (Hu et al., 2010; Vaithinathan 
et al., 2008). Studies on rat ovaries showed that in-vivo exposure to MXC (100 mg/kg) 
significantly reduces luteinizing hormone receptor expression in large antral follicles and 
significantly reduces CYP11A1 immunoreactivity in the ovaries (Armenti et al., 2008). In 
addition, another study in rat Leydig cells showed that HPTE decreases testosterone production 
by inhibiting the mRNA levels of Cyp11a1 (Akingbemi et al., 2000). Another study in rat testis 
showed that MXC reduces STAR protein levels (Vaithinathan et al., 2008). In the present study, 
MXC up-regulated the Star mRNA expression levels transiently at 48 h and inhibited Star 
expression by 96 h. A similar increase in Star levels was previously reported in granulosa cells at 
48 h in response to HPTE in the presence of db-cAMP (Zachow and Uzumcu, 2006). These data 
suggest that MXC may affect STAR expression differently in the testes and ovary. In the ovary, 
it is possible that Star overexpression is an attempt to increase the transfer of cholesterol to the 
mitochondria to increase substrate for Cyp11a1 and compensate for inhibition of hormonal levels 
present downstream in the steroidogenic pathway.  
In addition to E2 biosynthetic enzymes, E2 metabolic enzymes such as Cyp1a1 and 
Cyp1b1 are important in maintenance of E2 levels. TCDD is the classical halogenated aromatic 
hyrdrocarbon that has been shown to induce Cyp1a1 and Cyp1b1 enzymes in different tissues, 
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including granulosa cells of the ovary (Bofinger et al., 2001; Dasmahapatra et al., 2001; 
Whitlock, 1993). Cyp1a1 and Cyp1b1 are involved in C-2 and C-4 hydroxylations of E2 
respectively, leading to formation of catecholestrogens (Spink et al., 1992, 1994). In the present 
study, levels of Cyp1b1 were measured as they are shown to be expressed constitutively at higher 
levels compared to Cyp1a1 in the ovary (Dasmahapatra et al., 2001). Cyp1b1 levels were 
reduced at 24 h (MXC 100 μg/ml) and reached normal levels by 48 h, but significantly increased 
at 96 h to levels similar to those produced by TCDD (10nM). At 24 h, MXC did not alter the 
expression of steroidogenic enzymes, but it decreased expression of metabolic enzymes, 
resulting in no change in steroidogenesis and leading to no change in E2 levels. At 48 h, MXC 
inhibited steroidogenic enzymes, but not metabolic enzymes, resulting in decreased 
steroidogenesis with no changes in E2 metabolism, which finally lead to decreased E2 levels.  At 
96 h, MXC decreased steroidogenic enzymes and increased metabolic enzymes, resulting in 
decreased synthesis and increased clearance of E2, thus leading to further decrease in E2 levels. 
Thus, these data show that both steroidogenesis and metabolism of E2 were affected by MXC 
over time. 
Collectively, our results show that MXC decreases steroidogenic enzymes and increases 
metabolic enzymes (Cyp1b1) in mouse antral follicles. The reduction in steroidogenic enzymes 
likely leads to decreased synthesis of androgens and E2. Further, increase in the metabolic 
enzyme Cyp1b1 likely increases metabolism of E2 in follicles. Together, with decreased 
availability of hormone precursors and increased expression of metabolic enzyme Cyp1b1, MXC 
causes significant decrease in E2 levels and these low levels of steroids may contribute to MXC-
induced inhibition of follicle growth. The reasons for all these MXC-induced changes are 
unknown, but could include one or more common factors upstream of enzyme expression. MXC 
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as well as its metabolites have been shown to bind both nuclear and membrane estrogen 
receptors. Thus, it is possible that MXC binds to estrogen receptors and that this leads to changes 
in gene expression, which eventually leads to changes in steroidogenesis and follicle growth. 
Future studies will determine whether this is the case.  
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3.6 Figures and Legends 
Figure 3.1 Effect of in vitro MXC exposure on antral follicular growth 
 
Antral follicles isolated mechanically from CD-1 mice were exposed to vehicle control (DMSO) 
or MXC (1-100 μg/ml) for 96 h. Growth of follicles was monitored during culture, recorded in 
μm and reported as percentage change. Data represent means ± SE from 3 separate experiments 
[* indicates significant difference from controls (n= 12-16 follicles per treatment; p≤0.05)].  
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Figure 3.2 Effect of in vitro MXC exposure on estradiol (E2) levels 
 
Antral follicles isolated mechanically from CD-1 mice were exposed to vehicle control (DMSO) 
or MXC (1-100 μg/ml) and cultured for 24, 48, and 96 h. The media were subjected to 
measurements of E2 levels by enzyme-linked immunosorbent assay (ELISA). (A) E2 levels at 24 
h (B) E2 levels at 48 h  (C) E2 levels at 96 h. Data represent means ± SEM from 3 separate 
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experiments [* indicates significant difference from controls (n=9-12 follicles per treatment; 
p≤0.05)]. 
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Figure 3.3 Effect of in vitro MXC exposure on testosterone levels 
 
Antral follicles isolated mechanically from CD-1 mice were exposed to vehicle control (DMSO) 
or MXC (1-100 μg/ml) and cultured for 24, 48, and 96 h. The media were subjected to 
measurements of testosterone levels by ELISA. (A) testosterone levels at 24 h (B) testosterone 
levels at 48 h  (C) testosterone levels at 96 h. Data represent means ± SEM from 3 separate 
experiments [* indicates significant difference from controls (n=9-12 follicles per treatment; 
p≤0.05)]. 
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Figure 3.4 Effect of in vitro MXC exposure on androstenedione levels 
 
Antral follicles isolated mechanically from CD-1 mice were exposed to vehicle control (DMSO) 
or MXC (1-100 μg/ml) and cultured for 24, 48, and 96 h. The media were subjected to 
measurements of androstenedione levels by ELISA. (A) androstenedione levels at 24 h (B) 
androstenedione levels at 48 h  (C) androstenedione levels at 96 h. Data represent means ± SEM 
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from 3 separate experiments [* indicates significant difference from controls (n=9-12 follicles 
per treatment; p≤0.05)]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
62 
 
 
 
Figure 3.5 Effect of in vitro MXC exposure on progesterone (P4) levels 
 
Antral follicles isolated mechanically from CD-1 mice were exposed to vehicle control (DMSO) 
or MXC (1-100 μg/ml) and cultured for 24, 48, and 96 h. The media were subjected to 
measurements of P4 levels by ELISA. (A) P4 levels at 24 h (B) P4 levels at 48 h  (C) P4 levels at 
96 h. Data represent means ± SEM from 3 separate experiments [† p=0.065 using linear 
regression (n=9-12 follicles per treatment)]. 
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Figure 3.6 Aromatase (Cyp19a1) levels in response to MXC 
 
Antral follicles isolated mechanically from CD-1 mice were exposed to vehicle control (DMSO) 
or MXC (1-100 μg/ml) and cultured for 24, 48, and 96 h. Cyp19a1 mRNA expression was 
measured in antral follicles using qPCR. Data represent means ± SEM from 3 separate 
experiments [n=12-14 follicles per treatment; *p≤0.05 compared to 24 h; Bars with different 
letters are significantly different from each other within each time point].  
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Figure 3.7 17β-hydroxysteroid dehydrogenase (Hsd17b1) levels in response to MXC 
 
Antral follicles isolated mechanically from CD-1 mice were exposed to vehicle control (DMSO) 
or MXC (1-100 μg/ml) and cultured for 24, 48, and 96 h. Hsd17b1 mRNA expression was 
measured in antral follicles using qPCR. Data represent means ± SEM from 3 separate 
experiments [n=12-14 follicles per treatment; *p≤0.05 compared to 24 h; Bars with different 
letters are significantly different from each other within each time point]. 
 
 
 
 
 
 
 
 
24 h 48 h 96 h
0.00
0.60
1.20
1.80
2.40
H
sd
17
b1
/ß
-a
ct
in
 (g
e)
DMSO
MXC1µg/ml
MXC10µg/ml
MXC100µg/ml
a
b
a
ab
a
a
b
ab
a
b
a
ab
*
65 
 
 
 
Figure 3.8 17α-hydroxylase/17,20-lyase (Cyp17a1) levels in response to MXC 
 
Antral follicles isolated mechanically from CD-1 mice were exposed to vehicle control (DMSO) 
or MXC (1-100 μg/ml) and cultured for 24, 48, and 96 h. Cyp17a1 mRNA expression was 
measured in antral follicles using qPCR. Data represent means ± SEM from 3 separate 
experiments [n=12-14 follicles per treatment; *p≤0.05 compared to 24 h; Bars with different 
letters are significantly different from each other within each time point; † p≤0.05 using linear 
regression]. 
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Figure 3.9 3β-hydroxysteroid dehydrogenase (Hsd3b1) levels in response to MXC 
 
Antral follicles isolated mechanically from CD-1 mice were exposed to vehicle control (DMSO) 
or MXC (1-100 μg/ml) and cultured for 24, 48, and 96 h. Hsd3b1 mRNA expression was 
measured in antral follicles using qPCR. Data represent means ± SEM from 3 separate 
experiments [n=12-14 follicles per treatment; *p≤0.05 compared to 24 h; Bars with different 
letters are significantly different from each other within each time point].  
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Figure 3.10 Cholesterol side chain cleavage enzyme (Cyp11a1) levels in response to MXC 
 
Antral follicles isolated mechanically from CD-1 mice were exposed to vehicle control (DMSO) 
or MXC (1-100 μg/ml) and cultured for 24, 48, and 96 h. Cyp11a1 mRNA expression was 
measured in antral follicles using qPCR. Data represent means ± SEM from 3 separate 
experiments [n=12-14 follicles per treatment; Bars with different letters are significantly 
different from each other within each time point]. 
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Figure 3.11 Steroidogenic acute regulatory protein (Star) in response to MXC 
 
Antral follicles isolated mechanically from CD-1 mice were exposed to vehicle control (DMSO) 
or MXC (1-100 μg/ml) and cultured for 24, 48, and 96 h. Star mRNA expression was measured 
in antral follicles using qPCR. Data represent means ± SEM from 3 separate experiments [n=12-
14 follicles per treatment; *p≤0.05 compared to 24 h; Bars with different letters are significantly 
different from each other within each time point]. 
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Figure 3.12 Cytochrome P450 1b1 (Cyp1b1) levels in response to MXC 
 
Antral follicles isolated mechanically from CD-1 mice were exposed to vehicle control (DMSO) 
or MXC (1-100 μg/ml) and cultured for 24, 48, and 96 h. Cyp1b1 mRNA expression was 
measured in antral follicles using qPCR. Data represent means ± SEM from 3 separate 
experiments [n=12-14 follicles per treatment; *p≤0.05 compared to 24 h; Bars with different 
letters are significantly different from each other within each time point]. 
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3.7 Table Real-time qPCR primer accession numbers, abbreviations, and sequences.  
 
Accession no. Gene name Abbreviation 
Annealing/
extension 
temperatu
re (⁰C) 
Forward Reverse 
NM_007393.3 actin, beta Actb 57.3 
5’- 
GGGCACAGTGTGGG
TGAC- 3’ 
5’- 
CTGGCACCACACCTT
CTAC- 3’ 
NM_009994.1 
cytochrome 
P450, family 
1, subfamily 
b, polypeptide 
1 
Cyp1b1 60 
5’- 
GCGACGATTCCTCCG
GGCTG- 3’ 
5’- 
TGCACGCGGGCCTGA
ACATC- 3’ 
NM_019779.3 
cytochrome 
P450, family 
11, subfamily 
a, polypeptide 
1 
Cyp11a1 60 
5’- 
AGATCCCTTCCCCTG
GTGACAATG- 3’ 
5’- 
CGCATGAGAAGAGTA
TCGACGCATC- 3’ 
NM_007809.3 
cytochrome 
P450, family 
17, subfamily 
a, polypeptide 
1 
Cyp17a1 56.2 
5’- 
CCAGGACCCAAGTG
TGTTCT- 3’ 
5’- 
CCTGATACGAAGCAC
TTCTCG- 3’ 
NM_007810.3 
cytochrome 
P450, family 
19, subfamily 
a, polypeptide 
1 
Cyp19a1 55.3 
5’- 
CATGGTCCCGGAAA
CTGTGA- 3’ 
5’- 
GTAGTAGTTGCAGGC
ACTTC- 3’ 
NM_008293.3 
hydroxy-
delta-5-
steroid 
dehydrogenas
e, 3 beta- and 
steroid delta-
isomerase 1 
Hsd3b1 59.4 
5’- 
CAGGAGAAAGAACT
GCAGGAGGTC- 3’ 
5’- 
GCACACTTGCTTGAA
CACAGGC- 3’ 
NM_010475.1 
hydroxysteroi
d (17-beta) 
dehydrogenas
e 1 
Hsd17b1 58 
5’- 
ACTGTGCCAGCAAG
TTTGCG- 3’ 
5’- 
AAGCGGTTCGTGGAG
AAGTAG- 3’ 
NM_011485.4 
steroidogenic 
acute 
regulatory 
protein 
Star 57.5 
5’- 
CAGGGAGAGGTGGC
TATGCA- 3’ 
5’- 
CCGTGTCTTTTCCAAT
CCTCTG- 3’ 
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CHAPTER IV 
 
Methoxychlor induces atresia by altering Bcl2 factors and inducing caspase activity 
 
4.1 Abstract 
The organochlorine pesticide methoxychlor (MXC) is an endocrine disrupting chemical 
that has been shown to affect reproductive functions in adult females by causing persistent 
estrous cyclicity, reduced fertility, and ovarian atrophy. MXC is widely used in many 
countries to prevent and kill various species of insects that attack field crops, trees, vegetables, 
fruits, gardens, stored grain, livestock, and domestic pets. MXC reduces fertility by increasing 
atresia of antral follicles and by decreasing numbers of healthy antral follicles in adult female 
mice. However, the mechanism by which MXC causes follicular atresia is unknown. Previous 
studies have shown that MXC causes atresia at 96 h, in part, by increasing the pro-apoptotic 
factor Bax and decreasing the anti-apoptotic factor Bcl2 in antral follicles. Further, Bcl2 
overexpression and Bax deletion help to protect antral follicles from MXC-induced atresia. 
Presently, the earliest time at which MXC induces atresia is unknown and whether it alters 
other pro-apoptotic and anti-apoptotic factors in the antral follicles is also unknown. Thus, this 
work was designed to test the hypothesis that MXC induces atresia at early time points and 
that it also alters other pro-apoptotic (Bok and Casp3) and anti-apoptotic factors (Bcl-xL) in 
addition to Bcl2 and Bax. In addition, we also hypothesized that MXC alters caspase activity 
in the follicles. To test this hypothesis, antral follicles were mechanically isolated from 
ovaries of CD1 female mice aged 35-40 days. The isolated antral follicles (10-15 per 
treatment) were cultured in supplemented α-minimum essential media in the presence of 
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vehicle control (dimethylsulfoxide; DMSO) or MXC (1, 10, 100 μg/ml) for 24, 48, and 96 
hours at 37⁰C and 5%CO2. At selected times, follicles were subjected to histological analysis 
of atresia or collected and snap frozen. RNA was extracted from frozen follicles, cDNA was 
synthesized and then subjected to quantitative real-time PCR for the measurement of mRNA 
levels of Bax, Bcl2, Bcl-xL, Bok, and Casp3. The results indicate that at 24 h, MXC decreased 
Bok and Bcl-xL mRNA levels (p≤0.05, n=3) and increased Bax mRNA levels (p≤0.05, n=3). 
MXC did not affect Casp3 and Bcl2 mRNA levels at this time point.  At 48 h, MXC decreased 
Casp3 mRNA levels (p≤0.05, n=3), but did not affect expression of the other pro-apoptotic 
and anti-apoptotic genes. At 96 h, MXC significantly increased expression of Bcl2, Bcl-xL, 
and Bax mRNA levels (p≤0.05, n=3), but did not affect Bok and Casp3 mRNA levels. 
Caspase activities were increased at all time points. We also found that MXC exposure 
increases Bax as early as 24 h, but it does not induce changes in Bcl2 expression at this time 
point. This increase in Bax/Bcl2 ratio at 24 h, activates Casp3/7 activities which may lead to 
morphological atresia beginning at 48 h. Collectively, these results show that MXC alters both 
pro-apoptotic factors and anti-apoptotic factors in cultured antral follicles. These data suggest 
that MXC may induce atresia by altering the balance between several pro-apoptotic and anti-
apoptotic factors in antral follicles.  
 
4.2 Introduction 
The ovaries of female mammals contain a fixed number of primordial follicles at the time 
of birth (Hirshfield, 1991). These primordial follicles grow into more mature follicle stages 
known as primary, pre-antral, and antral follicles. During the reproductive lifespan, a constant 
stream of follicles grows from the primordial to the antral stage. Antral follicles are the only type 
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of follicles capable of releasing a fertilizable oocyte and they are the major sites of synthesis of 
steroid hormones such as estrogens. Although a few antral follicles ovulate and become 
fertilized, between 95-99% of all follicles die via an apoptotic process known as atresia. 
 The endocrine disrupting chemical methoxychlor (MXC) is an organochlorine pesticide, 
which is primarily used against various species of insects that attack field crops, trees, 
vegetables, fruits, gardens, stored grain, livestock and domestic pets (ATSDR, 2002). MXC 
specifically targets antral follicles in the ovary and its exposure leads to adverse reproductive 
functions in adult female mice by causing persistent estrus, ovarian atrophy, and follicular atresia 
(Eroschenko et al., 1997; Martinez and Swartz, 1991). Exposure to MXC during pregnancy in 
female mice revealed a significant increase in atretic follicles in female litters. A residual effect 
of MXC was observed as a significant advance in the time of vaginal opening in the second 
generation of litters (Swartz and Corkern, 1992). In vivo studies in mice have shown that MXC 
causes antral follicle toxicity, characterized by an increased percentage of atretic follicles and a 
decreased number of healthy antral follicles compared to controls (Borgeest et al., 2002). Many 
in vitro studies also have shown that MXC inhibits follicle growth and increases atresia of 
cultured mouse antral follicles (Gupta et al., 2006; Miller et al., 2005).   
Previous studies have only determined that MXC causes atresia of antral follicles after 
chronic (96 h) exposure in vitro. However, they have not determined if acute MXC exposure 
causes atresia nor have they determined the time course of onset of atresia with MXC exposure. 
Such information is critical for understanding the effects of MXC on ovarian follicles and for 
delineating the mechanism involved in MXC induced atresia. Thus, the current study examined 
both acute (24 - 48 h) and chronic (96 h) exposure to MXC to determine the earliest time point at 
which MXC induces atresia. 
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Despite the potential adverse reproductive abnormalities associated with MXC exposure, 
little is also known about the mechanisms by which MXC induces atresia in antral follicles. The 
present study was designed to identify whether the mechanism by which MXC destroys antral 
follicles involves Bcl2 family members and caspases. Bcl2 family members include two distinct 
groups: pro-apoptotic factors that promote apoptosis (e.g., Bax, Bok) and anti-apoptotic factors 
that promote cell survival (e.g., Bcl2, Bcl-xL) (Hsu and Hsueh, 2000; White, 1996). The fate of 
follicles depends on the balance between these different pro-apoptotic and anti-apoptotic factors. 
Bcl2 and Bax in particular are major regulators of follicular atresia in the mammalian ovary 
(Flaws et al., 2001; Hsu et al., 1996).  There are many functions of Bcl2 family members, but 
their primary roles are to regulate mitochondrial membrane homeostasis and the release of 
cytochrome c from the mitochondrial intermembrane space, both of which are decisive steps in 
apoptosis.  Pro-apoptotic factors such as Bax dimerize with the anti-apoptotic factor Bcl2; thus 
relieving the apoptotic protease activating factor-1 (Apaf-1) from suppression by Bcl2 proteins 
and promoting caspase activation. Additionally, these pro-apoptotic factors alter mitochondrial 
membrane homeostasis and increase cytochrome c release by forming pores in the outer 
mitochondrial membrane and opening the permeability transition pore following mitochondrial 
permeability transition, while anti-apoptotic factors such as Bcl2 counteract these actions. 
Cytochrome c interacts with Apaf-1 and procaspase 9 to form an apoptosome. Apoptosome 
formation results in activation of caspase 9 and subsequent activation of downstream caspases, 
which in turn results in DNA fragmentation (Hsu and Hsueh, 2000). Given the roles of pro-
apoptotic and anti-apoptotic factors in regulating atresia, the proposed work was designed to test 
the hypothesis that MXC induces atresia by altering pro-apoptotic and anti-apoptotic factors in 
the antral follicles of the ovary. Specifically, we examined the effects of MXC on expression of 
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Bcl2, Bcl-xL, Bax, Bok, and caspase levels and activity after both acute and chronic MXC 
exposure. 
 
4.3 Materials and Methods 
Chemicals: MXC (99% pure) was purchased from Chemservice (West Chester, PA). Stock 
solutions of MXC for in vitro experiments were prepared using vehicle control 
(diemthylsulfoxide; DMSO) (Sigma, St. Louis MO) as a solvent, and in various concentrations 
(2, 20, and 200 mg/ml) that permitted an equal volume of solvent to be added to individual 
culture wells for each treatment group. Thus, final concentrations of MXC in culture were 1, 10, 
and 100 μg/ml (ppm). The doses used in these experiments were selected based on previously 
published studies showing that these concentrations of MXC induce toxicity in antral follicles, 
granulosa cell culture models, and in uterine leiomyoma cells (Chedrese and Feyles, 2001; Gupta 
et al., 2006; Miller et al., 2005). The selected doses are environmentally relevant. Environmental 
levels of MXC range from 40–160 ppm in waters downstream of areas exposed to MXC 
(Wallner et al., 1969) to 4 ng/kg/day in humans exposed through food products (ATSDR, 2002). 
These concentrations are also relevant to occupational exposure levels. Normally, serum levels 
of MXC are reported to be below the level of detection.  However, a study involving an 
occupational exposure in farm workers has shown that MXC concentrations in serum can reach 
up to 5.16 µg/ml (ATSDR, 2002). Thus, the occupational exposure dose is much higher than 
normal human exposure and lies between the doses used in the present experiments. For controls 
and MXC treatment groups, DMSO was used at 0.05%, which is able to solubilize MXC in 
aqueous media. DMSO, ITS (insulin, transferrin, selenium), penicillin, and streptomycin were 
obtained from Sigma-Aldrich (St. Louis, MO). Alpha-minimal essential media (α-MEM) was 
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obtained from Invitrogen (Carlsbad, CA). Human recombinant follicle stimulating hormone 
(rFSH) was obtained from Dr. A.F. Parlow from the National Hormone and Peptide Program 
(Harbor-UCLA Medical Center, Torrance, CA). Fetal bovine serum (FBS) was obtained from 
Atlanta Biologicals (Lawrenceville, GA).  
 
Animals: Adult female cycling CD-1 mice were purchased from Charles River Laboratories 
(Charles River, CA) and housed in the core animal facility located at College of Veterinary 
Medicine, University of Illinois and maintained on 12L:12D cycles. Mice were housed in the 
animal facility for at least two days to relieve transportation stress, given ad libitum food and 
water, and temperature was maintained at 22±1 °C. Animals were euthanized at 35-39 days of 
age by carbon dioxide (CO2) inhalation followed by cervical dislocation. The ovaries were 
removed and antral follicles were isolated as explained below. The University of Illinois 
Institutional Animal Care and Use Committee approved all protocols involving animal care, 
euthanasia, and tissue collection.  
 
Antral follicle culture: Ovaries were removed and antral follicles were isolated from the ovaries 
of mice between 35-39 days old because this time point was used in previous studies, and this is 
the age at which mice are cycling young adults (Borgeest et al., 2004; Basavarajappa et al., 
2011). Antral follicles were isolated mechanically from the ovaries based on relative size and 
interstitial tissue was removed using fine watch-maker forceps.  About 3-4 mice were used per 
experiment and they yielded approximately 20-30 follicles per mouse. Once follicles were 
isolated, they were placed individually in wells of a 96-well culture plate with 150 µl of 
unsupplemented α-MEM prior to treatment. A dose response regimen of MXC (1-100 μg/ml) 
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and vehicle controls was individually prepared in supplemented α-MEM. For treatment, 
unsupplemented α-MEM was removed from each well and replaced with 150 μl of supplemented 
α-MEM containing MXC or DMSO. The follicles were cultured in supplemented media 
according to previously described protocols (Basavarajappa et al., 2011). Follicles then were 
incubated for 24, 48, and 96 hours (h). Non-treated controls (supplemented medium alone) were 
used in each experiment as a control for culture conditions. At the end of 24, 48, and 96 h follicle 
cultures, follicles were collected, snap frozen, and stored at -80⁰C for later use. Follicle cultures 
were repeated three times to obtain enough power for statistical analysis.    
 
Histological evaluation of atresia: At selected times in culture, follicles were collected in 
Dietrick’s solution and processed through series of washes with ethanol: 70% for 10 min, 85% 
for 10 min, 95% for 7 min (2X), and 100% for 7 min (2X). The follicles were embedded in 
plastic blocks using Technovit 7100 kits from Heraeus Kulzer GmbH, Germany. The follicles 
were incubated in a pre-infiltration medium for one hour and then with infiltration medium 
overnight before they were embedded in plastic blocks using embedding medium. Pre-infiltration 
solution was prepared with one part 100% ethanol and one part base solution. Infiltration 
solution was prepared with 1 gm of hardener-1 with 100 ml of base solution. Embedding 
medium was prepared by adding 1 ml of hardener-2 to 15 ml of infiltration solution. 
The follicles embedded in plastic blocks were sectioned into 2 µm sections using a 
microtome. Follicle sections were stained with Lee’s methylene blue-basic fuchsin stain for 30 
sec and washed with distilled water before they were cover slipped. Each follicle section was 
examined for level of atresia (follicle death) as evidenced by the presence of apoptotic bodies 
and reported at the highest level observed throughout the tissue. Follicles were rated on a scale of 
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1-4 for the presence of apoptotic bodies: 1= healthy, 2 = less than 10% apoptotic bodies (early 
atresia), 3 = 11-30% apoptotic bodies (mid atresia), 4 = greater than 30% apoptotic bodies (late 
atresia) as previously described by Miller et al. (2005). Ratings were averaged and plotted to 
compare the effect of chemical treatments on atresia levels. 
 
Quantitative real-time polymerase chain reaction (qPCR): Total RNA was isolated from frozen 
follicles using the RNeasy Micro Kit (Qiagen, Inc., Valencia, CA) following the manufacturer’s 
protocol. RNA was treated with DNAse to remove any possible genomic DNA contamination. 
The concentration of RNA in each sample was measured at 260 nm using the Nanodrop ND1000 
UV-Vis spectrophotometer (Nanodrop Technologies, Wilmington, DE). The cDNA was 
synthesized by reverse transcribing mRNA (50 ng) using an iScript cDNA synthesis kit (Bio-
Rad, Hercules, CA) according to the manufacturer’s instructions. The cDNA was diluted to 1:2 
with nuclease free water. 
qPCR was conducted using a CFX96 Real-time System C1000 Thermal Cycler (Bio-
Rad). All samples were measured in triplicate, and each reaction contained 2 μL of diluted 
cDNA, 0.6 μL (300nM) of gene-specific primers (Integrated DNA Technologies, Inc, Coralville, 
IA, Table 1), 2.4 μL of nuclease-free water, and 5 μL of SsoFast EvaGreen Supermix (Bio-Rad) 
for a final volume of 10 μL. The qPCR program consisted of an enzyme activation step (95 °C 
for 1 min), an amplification and quantification program [40 cycles of 95 °C for 10 sec, 60 °C 
annealing/extension for 10 sec, single fluorescence reading], a 72 °C for 5 min step, a melt curve 
(65 - 95 °C heating 0.5 °C per second with continuous fluorescence readings) and a final step at 
72 °C for 5 min.  
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Primer sequences are shown in Table 1. The specificity of each primer was tested using 
BLASTN2.218+ and by the presence of a single peak in the melt curve analysis. In addition, 
each product was run on 2% agarose gels to confirm the product size. A standard curve was 
generated from six serial dilutions of one of the samples (1:2, 1:4, 1:8, 1:16, 1:32, and 1:64); 
thus, allowing analysis of the amount of cDNA in the exponential phase. β-Actin was used as a 
reference gene. Final values were expressed as genomic equivalents and were calculated as the 
ratio of each gene to β-actin. The reported data were obtained from the mean expression values 
of 3-4 separate culture experiments. 
 
Caspase activity assay: Caspase activity in the cultured antral follicles was measured using the 
Caspase-Glo 3/7 Assay Kit from Promega. The follicles were cultured for 24, 48, and 96 h and 
then transferred with 100 µl of medium to a white-walled 96 well plate. Caspase-Glo 3/7 assay 
reagent (100 µl) was added and the plate was incubated at room temperature for 150 min. The 
caspase-3/7 present in the follicles cleaves the luminogenic substrate containing the DEVD 
sequence, releasing aminoluciferin, which in turn acts as a substrate for luciferase emitting 
luminescence. The amount of luminescence is a direct measurement of the caspase activity. The 
luminescence was captured using Synergy 2 Alpha Microplate Reader (Biotek). 
 
Statistical analysis: All data were analyzed using SPSS statistical software (SPSS Inc., Chicago, 
IL). For all comparisons, statistical significance was assigned at p ≤ 0.05. Comparisons between 
DMSO and the different doses of MXC were conducted on data obtained from 3 to 4 separate 
experiments using one-way analysis of variance (ANOVA) or Kruskal-Wallis test followed by 
Tukey's post hoc test or a test for linear regression or Mann-Whitney test when applicable. 
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4.4 Results 
Effect of MXC on atresia    
Previous studies have shown that MXC induces atresia of mouse antral follicles at 96 h of 
in vitro culture (Gupta et al., 2006; Miller et al., 2005). In the present study, we confirmed these 
previous findings by showing that MXC induces atresia at 96 h (MXC 100 µg/ml) (Fig.1). We 
also expanded previous studies by determining the earliest time at which MXC induces atresia. 
At 24 h, MXC did not induce atresia, but by 48 h, MXC (1, 10 and 100 µg/ml) increased follicle 
atresia ratings compared to vehicle control (DMSO) (Figure 4.1).  
 
Effect of MXC on expression of pro-apoptotic and anti-apoptotic factors  
 Since MXC induced atresia in antral follicles, we next examined whether the induction of 
atresia could be due to effects of MXC on mRNA expression of pro-apoptotic and anti-apoptotic 
factors. Upon treatment with MXC, the mRNA expression levels of the pro-apoptotic factor Bax 
were increased at all time points. MXC (100 µg/ml) significantly increased expression of Bax 
levels at 24, 48, and 96 h compared to DMSO (Figure 4.2). Interestingly, Bax levels were 
increased as early as 24 h, preceding the time of onset of morphological atresia.  
MXC did not affect Bcl2 levels at 24 and 48 h time points, but, MXC (100 µg/ml) 
significantly increased expression of Bcl2 at 96 h compared to DMSO (Figure 4.3). Interestingly, 
there were no changes in this anti-apoptotic factor at 24 h, the time point which precedes 
morphological atresia. 
From the mRNA expression values of Bax and Bcl2, we calculated the Bax/Bcl2 ratio 
across all time points. On treatment with MXC (100 µg/ml), Bax/Bcl2 ratios were increased at 24 
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h, not altered at 48 h, and decreased by 96 h (Figure 4.4). Thus, the Bax/Bcl2 ratio was increased 
as early as 24 h, preceding the onset of morphological atresia.  
Since MXC altered Bax, Bcl2, and their ratios, we wanted to measure the expression of 
other factors involved in induction of apoptosis in the antral follicles of the ovary. We found that 
MXC altered levels of another anti-apoptotic factor Bcl-xL. MXC significantly increased Bcl-xL 
levels at 24 and 96 h compared to DMSO (Figure 4.5). However, MXC did not affect Bcl-xL 
levels at 48 h. MXC exposure decreased levels of the pro-apoptotic factor Bok. At 24 h, MXC 
significantly decreased Bok levels compared to DMSO. However, MXC did not affect Bok levels 
at the 48 and 96 h time points (Figure 4.6).  
Since increased Bax/Bcl2 ratios are associated with induction of caspase activities (Basu 
and Haldar, 1998), we examined the levels of both Casp3 mRNA as well as Casp3 activities in 
antral follicles exposed to vehicle and MXC. We found that MXC treatment significantly 
decreased Casp3 levels at 48 h compared to DMSO, but it did not affect Casp3 levels at 24 and 
96 h. (Figure 4.7).  
 
Effect of MXC on CASPASE3/7 activity 
While MXC decreased mRNA expression levels of Casp3 at 48 h, it did not change 
Casp3 mRNA levels at a time that precedes the morphological onset of atresia. Studies, however, 
have shown that changes in caspase activities are important for induction of atresia rather than 
changes in mRNA levels. Thus, we measured the CASP3/7 activities in cultured antral follicles 
exposed to controls or MXC and found that MXC significantly increases CASP3/7 activities. 
Specifically, MXC (100 µg/ml) significantly increases CASP3/7 activities at 24, 48, and 96 h 
compared to DMSO (Figure 4.8).  
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4.5 Discussion 
The present studies were conducted to determine if acute exposure to MXC induces 
atresia and if MXC induces atresia of antral follicles by altering pro-apoptotic and anti-apoptotic 
factors. First, we examined the effects of both acute and chronic exposure to MXC on antral 
follicles. We found that MXC induces atresia as early as 48 h and that it continues to do so for up 
to 96 h. These findings are consistent with previous studies indicating that MXC increases atresia 
of mouse antral follicles at 96 h of culture (Miller et al., 2005). However, these studies also 
expand previous studies by showing that MXC induces atresia as early as 48 h. This suggests 
that acute exposure to MXC can quickly set into motion processes that result in death of antral 
follicles and that once the death process is initiated, it is not possible to stop it.  
 Given that MXC induces atresia in antral follicles, we next examined the effect of MXC 
on Bax and Bcl2 expression in follicles, as it is well known from previous studies that Bax and 
Bcl2 are important regulators of atresia in the ovary. Previous studies have shown that Bax 
deficient mice contain fewer atretic follicles than WT mice (Perez et al., 1999). Similarly, 
another study has shown that Bcl2 overexpression increases the number of primordial follicles at 
birth, possibly due to decreased apoptosis (Flaws et al., 2001). Further, mice deficient in Bcl2 
have an increased number of unhealthy primordial follicles and an increased number of apoptotic 
oocytes (Ratts et al., 1995). In addition to being important regulators of natural atresia, Bax and 
Bcl2 are involved in chemical induction of apoptosis.  The polyaromatic hydrocarbon 
dimethylbenz(a)anthracene has been shown to increase Bax levels, inducing apoptosis in mouse 
oocytes (Matikainen et al., 2001). Another chemical, 4-vinylcyclohexene diepoxide (VCD) also 
has been shown to induce atresia in small pre-antral follicles by altering Bcl2 family members 
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(Hu et al., 2001). Further, chromium has been shown to increase Bax and decrease Bcl2, 
inducing apoptosis in mouse ovarian granulosa cells (Banu et al., 2011). 
We found that MXC exposure increases Bax as early as 24 h, but does not induce 
changes in Bcl2 expression at this time point. This increases the Bax/Bcl2 ratio at 24 h, which 
may lead to morphological atresia beginning at 48 h. We also found that MXC increases Bax (48 
and 96 h), increases Bcl2 (96 h) and decreases in Bax/Bcl2 ratios (96 h) at later time points. This 
may be an attempt by the follicles to rescue themselves from MXC-induced atresia. However, 
our data indicate that once MXC induces atresia at 48 h, the follicles cannot recover from atresia 
throughout the culture. It is likely that any increase in anti-apoptotic factor Bcl2 cannot 
compensate for pro-apoptotic effects of Bax. The changes we observed with Bax and Bcl2 in 
response to MXC in vitro are consistent with previous in vivo studies showing that chronic 
exposure (20 days) to MXC induces atresia of antral follicles by increasing Bax and without 
altering Bcl2 levels in the mouse ovary (Borgeest et al., 2004). The data are also consistent with 
previous in vitro studies showing that MXC increases Bax (48 h) and decreases Bcl2 (96 h) 
expression (Miller et al., 2005).  
Given that the pro-apoptotic factor Bax plays a decisive role in MXC-induced atresia, we 
wanted to expand our findings by determining whether other pro- and anti-apoptotic factors are 
involved in MXC-induced atresia. Previous studies have shown that Bcl-xL acts as anti-apoptotic 
factor by preventing apoptosis in the ovary (Tilly et al., 1995). Hence, the current studies 
measured Bcl-xL expression levels in response to MXC in the antral follicles of the ovary. Our 
data indicate that MXC increases Bcl-xL levels at 24 and 96 h. However, these changes in Bcl-xL 
expression are not consistent with the time course for onset of MXC-induced atresia. Thus, it is 
likely that Bcl-xL factors are not involved in MXC-induced atresia. 
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We also examined the effect of MXC on the pro-apoptotic factor Bok. This factor has 
been shown to induce apoptosis in reproductive tissues (Hsu et al., 1997). Hence, the current 
studies measured Bok expression in response to MXC in the ovary. Our data indicate that MXC 
decreased Bok levels at 24 h, but did not affect Bok expression at other time points. These, 
changes in Bok at 24 h are not consistent with the morphological appearance of atresia that 
occurred at 48 h. Thus, it is possible that Bok is not involved in MXC-induced atresia.  It is 
possible that the decrease in Bok levels at 24 h is an attempt by the follicles to rescue themselves 
from atresia. However, attempts were not successful in rescuing atresia evident at 48 h and 
remains throughout culture.  
While changes in Bcl2 family members help regulate apoptosis, caspase3 is the critical 
rate limiting factor in the apoptotic pathway. In apoptotic cells, pro-caspase3 is cleaved and 
activated by Casp9, the activated Casp3 then autoregulates to increase the permeability of 
mitochondrial membrane by conversion of anti-apoptotic factors to pro-apoptotic factors, further 
amplifying Casp3 activity. Finally, Casp3 cleaves several proteins and DNA leading to formation 
of apoptotic bodies (Cheng et al., 1997). In the present study, we measured Casp3 mRNA and 
Casp3/7 activities in MXC treated follicles. Our data indicate that MXC decreases Casp3 mRNA 
levels at 48 h in the follicles. In contrast, MXC increases Casp3/7 activities at all the time points 
in the follicles. These data suggest that MXC-induced atresia is not regulated by changes in 
Casp3 mRNA expression. Instead, MXC-induced atresia is regulated by increase in Casp3 
activity. While to our knowledge, no studies have examined the effects of MXC on caspase 
activities in the ovary, some studies have shown that other chemicals induce Casp3 activity or 
protein levels in the ovarian cells. Several studies in granulosa cells have shown that acute 
exposure to molybdenum and chromium induce apoptosis by inducing Casp3 (Banu et al., 2011; 
92 
 
 
 
Kolesarova et al., 2010).  Other in vivo studies have shown that chronic exposure to VCD 
induces apoptosis in pre-antral follicles by inducing Casp3 (Thompson et al., 2005; Devine et al., 
2002). Our data are consistent with these studies in that chemicals including MXC cause 
apoptosis by inducing Casp3 activity in follicles or granulosa cells.   
In conclusion, the present studies provide evidence that acute exposure to MXC induces 
atresia as quickly as 48 h. The present studies also show that MXC exposure alters expression of 
key anti- and pro-apoptotic factors and increases caspase activity. At 24 h, MXC increases Bax 
levels and does not affect Bcl2 levels. This increases the Bax/Bcl2 ratio, which in turn may 
increase the mitochondrial permeability leading to activation of Casp3/7 activities. Thus, these 
early changes in Bax expression and Casp3/7 activity induce onset of morphological atresia 
beginning at 48 h. Once MXC-induced atresia occurs, the follicles cannot recover and continue 
to undergo atresia at 96 h (Fig.9). 
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4.6 Figures and Legends 
Figure 4.1 Effect of in vitro MXC exposure on antral follicular atresia 
 
 
Antral follicles isolated from CD-1 mice were exposed to vehicle control (DMSO) or MXC (1-
100 μg/ml) for 24, 48, or 96 h. At the end of culture, follicles were subjected to histological 
analysis of atresia. Data represent means ± SEM from 3 separate experiments (* indicates 
significant difference from vehicle controls; n= 4 - 6 follicles per treatment; p≤0.05).  
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Figure 4.2 Bax levels in response to MXC 
 
 
Antral follicles isolated from CD-1 mice were exposed to vehicle control (DMSO) or MXC (1-
100 μg/ml) and cultured for 24, 48, or 96 h. Bax mRNA levels were measured in antral follicles 
using qPCR. Data represent means ± SEM from 3 separate experiments (* indicates significant 
difference from vehicle controls; n=12-14 follicles per treatment; p≤0.05). 
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Figure 4.3 Bcl2 levels in response to MXC 
 
 
Antral follicles isolated from CD-1 mice were exposed to vehicle control (DMSO) or MXC (1-
100 μg/ml) and cultured for 24, 48, or 96 h. Bcl2 mRNA levels were measured in antral follicles 
using qPCR. Data represent means ± SEM from 3 separate experiments (* indicates significant 
difference from vehicle controls; n=12-14 follicles per treatment; p≤0.05). 
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Figure 4.4 Bax/Bcl2 ratios in response to MXC 
 
 
 
Antral follicles isolated from CD-1 mice were exposed to vehicle control (DMSO) or MXC (1-
100 μg/ml) and cultured for 24, 48, or 96 h. Using qPCR, mRNA levels of Bax and Bcl2 were 
measured in antral follicles and Bax/Bcl2 ratios were calculated. Data represent means ± SEM 
from 3 separate experiments (* indicates significant difference from vehicle controls; n=12-14 
follicles per treatment; p≤0.05). 
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Figure 4.5 Bcl-xL levels in response to MXC 
 
 
Antral follicles isolated from CD-1 mice were exposed to vehicle control (DMSO) or MXC (1-
100 μg/ml) and cultured for 24, 48, or 96 h. Bcl-xL mRNA levels were measured in antral 
follicles using qPCR. Data represent means ± SEM from 3 separate experiments (* indicates 
significant difference from vehicle controls; n=12-14 follicles per treatment; p≤0.05). 
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Figure 4.6 Bok levels in response to MXC 
 
 
Antral follicles isolated from CD-1 mice were exposed to vehicle control (DMSO) or MXC (1-
100 μg/ml) and cultured for 24, 48, or 96 h. Bok mRNA levels were measured in antral follicles 
using qPCR. Data represent means ± SEM from 3 separate experiments (* indicates significant 
difference from vehicle controls; n=12-14 follicles per treatment; p≤0.05). 
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Figure 4.7 Casp3 levels in response to MXC 
 
 
Antral follicles isolated from CD-1 mice were exposed to vehicle control (DMSO) or MXC (1-
100 μg/ml) and cultured for 24, 48, or 96 h. Casp3 mRNA levels were measured in antral 
follicles using qPCR. Data represent means ± SEM from 3 separate experiments (* indicates 
significant difference from vehicle controls; n=12-14 follicles per treatment; p≤0.05). 
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Figure 4.8 Casp3/7 activities in response to MXC 
 
 
 
Antral follicles isolated from CD-1 mice were exposed to vehicle control (DMSO) or MXC (1-
100 μg/ml) and cultured for 24, 48, or 96 h. At the end of culture, follicles were subjected to 
measurement of Casp3/7 activities. Data represent means ± SEM from 3 separate experiments (* 
indicates significant difference from vehicle control; n=12-14 follicles per treatment; p≤0.05). 
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Figure 4.9 Model of MXC-induced atresia 
 
 
 
Exposure to MXC at 24 h increases the Bax expression and does not alter Bcl2 expression, 
leading to an increased Bax/Bcl2 ratio. This increase in Bax/Bcl2 ratio leads to increase in 
Casp3/7 activity, which finally induces atresia at 48 h. Once atresia occurs, follicles fail to revive 
and continue to remain atretic at 96 h.  
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CHAPTER V 
 
Methoxychlor inhibits growth and induces atresia through aryl hydrocarbon receptor 
pathway in mouse ovarian antral follicles 
 
5.1 Abstract 
Methoxychlor (MXC) is an organochlorine pesticide used against pests and insects that 
attack crops, gardens, vegetables, pets, and livestock. MXC has been shown to reduce fertility, 
and to cause persistent estrus and ovarian atrophy. Further, MXC inhibits growth and induces 
atresia of mouse antral follicles in vitro.  Little is known, however, about the mechanisms by 
which MXC causes slow growth and atresia of antral follicles.  Several studies indicate that 
many chemicals act through the aryl hydrocarbon receptor (AHR) pathway and one study has 
shown that MXC binds to the AHR in liver cells. Thus, we hypothesized that MXC induces 
antral follicle toxicity through an AHR mediated pathway. The current study tested the 
hypothesis that MXC binds to AHR to inhibit follicle growth and induce atresia of antral 
follicles.  To test binding of MXC to AHR, we transfected granulosa cells with xenobiotic 
response element based reporter plasmids and found that MXC binds to AHR. To confirm 
whether MXC acts through the AHR pathway, antral follicles were surgically isolated from 
ovaries of C57BL/6 female wild-type (WT) and AHR null (AHRKO) mice aged 30-35 days. The 
isolated antral follicles (10-15 per treatment) were cultured in vehicle control 
(dimethylsulfoxide; DMSO) or MXC (1, 10, 100 μg/ml) for 168 h at 37ºC and 5%CO2 in α-
minimum essential media. During culture, follicle growth was monitored every 24 h by 
measuring follicular diameter on two perpendicular axes. After culture, the follicles were 
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subjected to histological analysis of atresia. The results indicate that MXC (10, 100 μg/ml) 
significantly inhibits follicular growth in wild-type antral follicles by 168 h. The results also 
indicate that MXC (10, 100 μg/ml) significantly induced atresia in WT antral follicles. 
Conversely, MXC (10 μg/ml) did not significantly inhibit follicle growth or induce atresia in 
AHRKO follicles. These data indicate that AHR deletion protects antral follicles against MXC 
induced slow growth and atresia.  Collectively, these data show that MXC acts through the AHR 
pathway to inhibit follicle growth and induce atresia in antral follicles of the ovary. 
 
5.2 Introduction 
 Endocrine disrupting chemicals (EDCs) such as pesticides, plasticizers, cosmetics, 
solvents, paints and pollutants are present in the environment. EDCs exert their toxicity by 
affecting the synthesis, secretion, transport, binding, action, and elimination of variety of 
hormones present in the body (Crisp et al., 1998). The EDC methoxychlor (MXC) is an 
organochlorine pesticide that is widely used in many parts of the world, primarily to prevent or 
destroy insects or pests that feed on field crops, gardens, fruits, vegetables, stored grain and 
domestic animals (ATSDR, 2002). MXC gained popularity in 1970s and replaced the potent 
chlorinated pesticide dichlorodiphenyltrichloroethane (DDT) after its usage was restricted in the 
US and other parts of the world. MXC was extensively used in the farming industry until it was 
banned in 2004 because of failure of registration with the EPA (Stuchal et al., 2006). Globally, 
humans and domestic animals are exposed to MXC through extensive usage of this chemical and 
in the US, through imported agricultural products.  
 MXC has been shown to induce persistent vaginal estrus, decrease ovarian weights, and 
increased atresia of large follicles in adult female mice (Martinez and Swartz, 1991). Exposure to 
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MXC in utero increases atretic follicles in F1a litters and the residual effect of MXC induces 
premature vaginal opening in F1b litters. In addition, mothers exposed to MXC have an 
increased gestation period and increased number of dead fetuses compared to vehicle controls 
during the first pregnancy (Swartz and Corkern, 1992). Neonatal exposure to MXC also induces 
ovarian atrophy, decreases relative ovarian weight, and decreases corpora lutea numbers 
(Eroschenko et al., 1995). Collectively, these previous studies indicate that MXC targets the 
ovary and affects fertility in laboratory rodents.  
 More recent studies indicate that MXC damages the ovary by inhibiting antral follicle 
growth and increasing atresia. In vivo studies in mice indicate that MXC specifically targets 
antral follicles by increasing the number of atretic antral follicles and decreasing the percentage 
of healthy antral follicles in the ovary (Borgeest et al., 2002). Several in vitro studies have also 
shown that MXC inhibits growth and increases atresia of mouse antral follicles (Miller et al., 
2005; Gupta et al., 2006).  
 While it is known that MXC inhibits growth and increases atresia of antral follicles, the 
mechanism by which it does so is unclear. Many studies indicate that other EDCs such as 
polychlorinated dibenzo-p-dioxins, polychlorinated dibenzofurans, and polyhalogenated 
biphenyls mediate their toxicity through the aryl hydrocarbon receptor (AHR) pathway (Okey et 
al., 1994; Poland et al., 1976). However, limited information is available about whether MXC 
works via the AHR pathway. One study by Han et al., (2007) suggests that MXC may bind to 
AHR, inhibiting the action of 2,3,4,8-tetrachlorodibenzo-p-dioxin (TCDD) in murine Hepa-
1c1c7 cells (Han et al., 2007). Thus, the current study was designed to determine the 
involvement of the AHR pathway in mediating the effects of MXC treatment on antral follicles 
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of the mouse ovary. Specifically, this study was designed to test the hypothesis that MXC works 
through the AHR to inhibit follicle growth and induce atresia.  
 
5.3 Materials and Methods 
Chemicals: MXC (99% pure) was purchased from Chemservice (West Chester, PA). Stock 
solutions of MXC for in vitro experiments were prepared using dimethylsulfoxide (DMSO) 
(Sigma, St. Louis MO) as a solvent, and in various concentrations (1.33, 13.33, and 133.33 
mg/ml) that permitted equal volume of solvent to be added to individual culture wells for each 
treatment group. Thus, final concentrations of MXC in culture were 1, 10, and 100 μg/ml (ppm). 
For controls and MXC treatment groups, DMSO was used at 0.075%, which is able to solubilize 
MXC in aqueous media without exerting toxicity to follicles. These doses were selected for in 
vitro studies based on previously published studies showing that these concentrations of MXC 
induce toxicity in antral follicles and granulosa cell culture models (Gupta et al., 2006; Miller et 
al., 2005). These concentrations are relevant to occupational exposure levels. The FDA 
monitored the chemical contaminants in food products in the United States and calculated the 
average daily intake of methoxychlor in adults was up to 4 ng/kg/day (ATSDR, 2002). Normally, 
serum levels were found to be below the level of detection. However, a study involving an 
occupational exposure in farm workers showed that MXC concentrations in serum could reach as 
high as 5.16 μg/ml (ATSDR, 2002). Thus, the occupational exposure dose is much higher than 
normal human exposure and lies between the doses used in the present experiments: MXC 1 
μg/ml and MXC 10 μg/ml. DMSO, ITS (insulin, transferrin, selenium), penicillin, and 
streptomycin were obtained from Sigma-Aldrich (St. Louis, MO). Alpha-minimal essential 
media (α-MEM) was obtained from Invitrogen (Carlsbad, CA). Human recombinant follicle 
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stimulating hormone (rFSH) was obtained from Dr. A.F. Parlow from the National Hormone and 
Peptide Program (Harbor-UCLA Medical Center, Torrance, CA). Fetal bovine serum (FBS) was 
obtained from Atlanta Biologicals (Lawrenceville, GA).  
 
Animals: Adult female cycling C57BL/6 female wild-type (WT) and AHR homozygous null 
(AHRKO) mice were housed in the core animal facility located at College of Veterinary 
Medicine, University of Illinois and maintained on 12L: 12D cycles. Mice were given ad libitum 
food and water, and temperature was maintained at 22±1 °C. Animals were euthanized at 30-35 
days of age by carbon dioxide (CO2) inhalation followed by cervical dislocation. The ovaries 
were removed and antral follicles were isolated as explained below. The University of Illinois 
Institutional Animal Care and Use Committee (IACUC) approved all protocols involving animal 
care, euthanasia, and tissue collection.  
 
Screening/genotyping AHRKO and WT mice: Mice were genotyped using polymerase chain 
reaction (PCR) - based assays. Briefly, ear punch tissues from pups were lysed in 25 μl of buffer 
(1M Tris pH 8.0, 5M NaCl, 0.5M EDTA, and 20% SDS) containing 2 μl of 20 mg/ml proteinase 
K (Qiagen Inc.,Valencia, CA). Digestion was carried out at 55°C for 1h followed by enzyme 
inactivation at 100°C for 3 min. Molecular grade water (73 µl) then was added to the lysate and 
this mixture was subjected to PCR using primers (1) Neo F: 5’- 
TTGGGTGGAGAGGCTATTCG - 3 ’ and (2) Neo R: 5’- CCATTTTCCACC ATGATATTCG - 
3’, which detect the insert in the AHR gene and primers (3) F: 5’- TCTTGGGCTCGATCT 
TGTGTCA - 3’ and (4) R: 5’- TTGACTTAATTCCTTCAGCGG - 3’, which detect the AHR 
gene.  
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The conditions for PCR were 94°C for 2 min of initial denaturation followed by 40 cycles 
at 94°C for 45 s, 55°C for 1 min, and 72°C for 3 min. PCR products then were subjected to 
agarose gel electrophoresis. The presence of a 672-bp fragment indicated that the mice were WT, 
the presence of 580-bp band indicated that the mice were AHRKO, and presence of both 673- 
and 580-bp bands indicated that mice were heterozygotes. Only WT and AHRKO homozygous 
mice were used in these experiments. 
 
Granulosa cell culture and Cignal reporter assay: Ovaries from 30-35 day old mice were 
collected and cleaned in petri dishes containing collection media (α-MEM media, 10% FBS, 200 
U/ml penicillin, 200 mg/ml streptomycin). They were then transferred to petri dishes containing 
supplemented media and were incubated for 20 - 30 min at 37⁰C. Supplemented media were 
prepared as previously described (Basavarajappa et al., 2011).  Granulosa cells (GC) were 
collected by puncturing follicles using syringe needles. GCs were counted using a 
hemocytometer chamber, and approximately 20,000 GCs were added to each well of a 96 well 
microplate and incubated at 37⁰C for 3 days with media changed daily.   
After 3 days of culture, when the cells reached 80-90 % confluence, GCs were 
transfected with negative control, positive control or xenobiotic response element (XRE) reporter 
plasmids (Cignal XRE reporter (luc) kit: SABiosciences) using Lipofectamine2000 (Invitrogen). 
Transfection was carried out according to manufacturer instructions for a transfection time of 18 
h. After the transfection, medium was replaced with supplemented medium containing either 
DMSO or MXC (1, 10, and 100 μg/ml) or the positive control TCDD (10 nM) and incubated for 
18 h. DMSO or MXC treatments were also added to negative controls to determine the specific 
effects and background reporter activity. The Dual-Glo Luciferase Reagent (Promega) was added 
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directly to medium to measure both firefly and renilla luminescences. TCDD was used as a 
positive control for induction of XREs because several studies indicate it binds the AHR with 
high affinity (Fisher et al., 1990; Poland et al., 1976). No-treatment controls were used as a 
control for culture conditions. XRE reporter plasmids contain a mixture of inducible AHR-
responsive firefly luciferase construct and constitutively expressing Renilla luciferase construct 
(40:1). Negative control contained a mixture of non-inducible firefly luciferase construct and 
constitutively expressing Renilla luciferase construct (40:1). Positive controls contained a 
mixture of constitutively expressing green fluorescence protein, constitutively expressing firefly 
luciferase, and constitutively expressing Renilla luciferase constructs (40:1:1). Renilla luciferase 
constructs acted as an internal control within each well.  
 
Antral follicle culture: Antral follicles were isolated from ovaries of WT and AHRKO mice 
between 30-35 days old because this is the age at which mice are cycling young adults 
(Basavarajappa et al., 2011; Gupta et al., 2009). Antral follicles were isolated mechanically from 
the ovaries based on appearance and relative size (diameter 200-400 μm) and interstitial tissue 
was removed using fine watch-maker forceps.  About 2-3 mice were used per experiment and 
they yielded approximately 30-40 follicles per mouse. Once follicles were isolated, they were 
placed in each well in 96 well culture plates containing 150 µl of unsupplemented medium. A 
dose response regimen of MXC (1-100 μg/ml) and vehicle control (DMSO) was individually 
prepared in supplemented α-MEM. The unsupplemented medium was replaced with 
supplemented medium containing either DMSO or MXC (1, 10, and 100 μg/ml). Non-treated 
controls were used in each experiment as a control for culture conditions. The unsupplemented 
medium was removed slowly so that follicles could attach to the bottom of wells. Each treatment 
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group in an experiment consisted of 10-15 follicles.  
 Follicles were cultured in supplemented medium according to protocol as previously 
described (Basavarajappa et al., 2011). Follicles then were incubated for 168 hours (h) with 
medium changed at 96 h. At the end of 168 h, media were collected and stored at -80⁰C for later 
use. In addition, some follicles were fixed in Dietrick’s solution for histological evaluation of 
atresia and some follicles were collected, snap frozen, and stored at -80⁰C for quantitative real 
time PCR as described below. Follicle cultures were repeated three times to obtain enough power 
for statistical analysis.    
 
Analysis of follicle growth: WT and AHRKO antral follicles were cultured as described above 
for 168 h. Follicle growth was examined in 24 h intervals by measuring follicle diameters across 
perpendicular axes with an inverted microscope equipped with a calibrated ocular micrometer. 
Antral follicles were considered as those having diameters of 200 µm or greater (Miller et al., 
2006), which correlates with the histological appearance of these follicles. Follicle diameter 
measurements were averaged among treatment groups and plotted to compare the effects of 
chemical treatments on growth over time.  
 
Histological evaluation of atresia: The follicles collected in Dietrick’s solution were processed 
through series of washes with ethanol: 70% for 10 min, 85% for 10 min, 95% for 7 min (2X), 
and 100% for 7 min (2X). They were then embedded in plastic blocks using Technovit 7100 kits 
from Heraeus Kulzer GmbH, Germany. The follicles were incubated in a pre-infiltration medium 
for one hour and then with infiltration medium overnight before they were embedded in plastic 
blocks using embedding medium. Pre-infiltration solution was prepared with one part 100% 
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ethanol : one part base solution and infiltration solution was prepared with 1 gm of hardener-1 
with 100 ml of base solution. Embedding medium was prepared by adding 1 ml of hardener-2 to 
15 ml of infiltration solution. 
The follicles embedded in plastic blocks were sectioned into 2 µm thin sections using a 
microtome. Follicle sections were stained with Lee’s methylene blue-basic fuchsin stain for 30 
sec and washed with distilled water before they were cover slipped. Each follicle section was 
examined for level of atresia (follicle death) as evidenced by the presence of apoptotic bodies 
and reported at the highest level observed throughout the tissue. Specifically, follicles were rated 
on a scale of 1-4 for the presence of apoptotic bodies: 1= healthy, 2 = less than 10% apoptotic 
bodies (early atresia), 3 = 11-30% apoptotic bodies (mid atresia), 4 = greater than 30% apoptotic 
bodies (late atresia), as previously described by Miller et al. (2005) (Miller et al., 2005). Ratings 
were averaged and plotted to compare the effect of chemical treatments on atresia levels. 
 
Hormone measurements: The media samples from at least 10-15 individual wells distributed 
equally across 3-4 experiments were randomly selected and subjected to enzyme-linked 
immunosorbent assays (ELISA) as described previously (Craig et al., 2010). Specifically, 
estradiol (E2) levels were measured in the media using kits from DRG International 
(Mountainside, NJ). The sensitivity of the ELISA was 9.714 pg/ml for E2. The intra-assay 
coefficient of variation (CV) was 4.7% and the inter-assay CV was 7.8%. The cross reactivity 
with other hormones for each type of kit was negligible.  
 
Statistical analysis: All data were analyzed using SPSS statistical software (SPSS Inc., Chicago, 
IL). For all comparisons, statistical significance was assigned at p ≤ 0.05. Comparisons between 
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DMSO and the different doses of MXC were conducted on data obtained from 3 to 4 separate 
experiments using one-way analysis of variance (ANOVA) or Kruskal-Wallis test followed by 
Tukey's post hoc test or Mann-Whitney test or a test for linear regression when applicable. 
 
5.4 Results 
Effect of MXC on XRE reporter activity 
 MXC has been shown to bind to the AHR in liver cells, but it was unknown whether 
MXC also binds to the AHR in ovarian cells. Hence, we conducted transfection studies using 
XRE based reporter plasmids in granulosa cells. We found that MXC (10 and 100 µg/ml) 
significantly induces XRE reporter activity. The MXC-induction of XRE reporter activity was 
similar to that induced by the positive control TCDD (Figure 5.1).  
  
Effect of MXC on WT and AHRKO follicle growth  
 Given our finding that MXC binds to the AHR, we next determined if MXC works 
through the AHR to inhibit follicle growth. Previous studies have shown that MXC inhibits 
growth of mouse antral follicles by 96 h of culture (Basavarajappa et al., 2011; Miller et al., 
2005). In the present study, we evaluated the effects of MXC on growth of WT and AHRKO 
follicles through 168 h of culture. Evaluation of growth in WT follicles showed that MXC at 10 
and 100 µg/ml significantly inhibited follicle growth compared to vehicle control (DMSO) at 96-
168 h. MXC at 1 µg/ml did not inhibit follicle growth at any time point (Figure 5.2). 
Interestingly, evaluation of growth in AHRKO follicles showed that only MXC 100 µg/ml 
inhibited follicle growth compared to DMSO. MXC at 1 and 10 µg/ml did not inhibit follicle 
growth and thus, AHRKO follicles grew similar to controls at these concentrations of MXC. 
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Further, MXC inhibited follicle growth at an earlier time point in WT follicles compared to 
AHRKO follicles. Specifically, MXC 100 µg/ml inhibited growth at 96 h in WT follicles, but not 
until 120 h in AHRKO follicles (Figure 5.3).  
 
Effect of MXC on WT and AHRKO follicle atresia 
 Since MXC is also known to induce atresia of antral follicles in vivo and in vitro, we next 
examined if it does so via an AHR pathway. In WT follicles, MXC at 10 and 100 µg/ml 
significantly increased atresia compared to DMSO.  However, MXC at 1 µg/ml did not increase 
atresia compared to control. In AHRKO follicles, only MXC at 100 µg/ml significantly increased 
atresia compared to DMSO. MXC at 1 µg/ml did not increase atresia compared to control 
(Figure 5.4). When we compared atresia in treated and control follicles across WT and AHRKO 
genotypes, MXC at 10 µg/ml significantly increased atresia in WT, but not AHRKO follicles 
(Figure 5.4).  
 
Effect of MXC on estradiol levels in WT and AHRKO follicles 
 MXC is also known to inhibit E2 levels. Further, normal levels of E2 are thought to help 
regulate normal follicle growth and atresia. Thus, we examined whether MXC decreases E2 
levels via the AHR. MXC significantly decreased estradiol levels in WT and AHRKO follicle 
types at the MXC 10 and 100 µg/ml doses, but not the MXC 1 µg/ml dose compared to DMSO 
(Figure 5.5).  
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5.5 Discussion 
The current studies were conducted to test the hypothesis that MXC inhibits follicle 
growth and induces atresia through the AHR pathway in mouse ovarian antral follicles. Our data 
indicate that MXC binds to AHR in ovarian cells and that it may work through the AHR to 
regulate the effects of MXC on follicle growth and atresia, but not estradiol levels.  
In cells, upon ligand binding, the AHR is activated and translocate into nucleus, where it 
forms a complex with aryl hydrocarbon nuclear translocator (ARNT). The liganded AHR-ARNT 
complex then acts as a transcriptional activator by binding to XREs present in 5’-flanking region 
of numerous genes including Cyp1a1 and Cyp1b1 (Denison and Whitlock, 1995). Studies have 
shown that the 5’-flanking region containing AHREs is responsible for the induction of Cyp1a1 
and Cyp1b1 (Okey et al., 1994). In the current studies, we first assessed whether MXC binds to 
AHR by transfecting a XRE-reporter (luc) plasmid into granulosa cells. We showed that MXC 
induces the XRE-reporter plasmid, suggesting that it binds to the AHR in the ovary. Our results 
are consistent with previous findings that MXC binds to AHR in Hepa-1c1c7 cells (Han et al., 
2007). Further, our results are consistent with an in vivo study in rats showing that MXC induces 
CYP1A1/1A2 activities in the liver (Oropeza-Hernandez et al., 2003). Interestingly, our data 
indicate that MXC (100 µg/ml) induces the XRE-reporter plasmid to the same degree as TCDD 
(10nM). TCDD and other polyaromatic hydrocarbons (PAHs) are known to bind to the AHR and 
induce the cytochrome P450 family of genes in different tissues, including the ovary (Okey et 
al., 1984; Okey and Vella, 1982; Poland et al., 1976). Studies in granulosa cells also have shown 
that TCDD induces Cyp1a1 and Cyp1b1 by increasing expression of Ahr (Dasmahapatra et al., 
2001).  
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Previous studies have shown that MXC inhibits follicle growth and induces atresia in 
cultured antral follicles (Miller et al., 2006; Gupta et al., 2006). Given that MXC binds the AHR, 
we next tested whether MXC inhibits follicle growth and induces follicular atresia via the AHR 
pathway. We found that deletion of AHR can rescue follicles from MXC (10 µg/ml) induced 
inhibition of follicle growth and MXC induced atresia. Interestingly, the rescue only occurred at 
the 10 µg/ml dose of MXC and not the 100 µg/ml dose of MXC.  
At the 10µg/ml dose, it is possible that MXC exclusively acts through AHR pathway to 
inhibit follicle growth and atresia. Hence, genetic deletion of AHR can rescue the MXC 
inhibition of follicle growth and atresia at that dose. However, at the 100 µg/ml dose, it is 
possible that in addition to AHR pathways, MXC works via other pathways such as non-genomic 
estrogen receptor pathways and androgen receptor pathways (Miller et al., 2006; Ghosh et al., 
1999; Waters et al., 2001). Thus, deleting only the AHR does not rescue antral follicles from 
inhibition of follicle growth and induction of atresia by MXC (100 µg/ml).  
Our results showed that the ability to rescue follicles from MXC-induced atresia is 
consistent with other studies showing that manipulation of the AHR rescues ovarian cells from 
other chemicals. For example: Studies have shown that AHR disruption by -napthoflavone 
(ANF) reduces the ability of 9,10-dimethylbenz(a)antracene-3,4-dihydrodiol (DMBA-DHD) to 
cause cell death and as a result increases the number of fetal oocytes (Matikainen et al., 2002; 
Matikainen et al., 2001). Another study also showed that AHR disruption by ANF reduces the 
effect of PAHs such as benzo(a)pyrene, 3-methylcholanthrene, and 7,12-
dimethylbenz(a)anthracene (DMBA) and as a result increases the numbers of primordial and 
primary follicular oocytes (Mattison et al., 1989; Shiromizu and Mattison, 1984, Shiromizu and 
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Mattison, 1985). To our knowledge this is the first study to show that genetical deletion of AHR 
rescues follicles from MXC induction of atresia.  
Our data show that MXC (10 and 100µg/ml) decreases estradiol levels in both WT and 
AHRKO follicles. These results are consistent with our previous studies that showed MXC 
decreases E2 levels in cultured follicles (Basavarajappa et al., 2011). Interestingly, we observed 
that AHR deletion did not rescue E2 levels in follicles. Thus, it is evident that AHR is not 
involved in controlling E2 levels in response to MXC.  
In summary, these results provide mechanistic information that MXC exerts toxicity 
through the AHR pathway in antral follicles.  The present data showed that MXC binds to AHR 
in granulosa cells of the ovary. In addition, current data confirmed previous data that MXC 
inhibits follicle growth and atresia in WT follicles. Further, we also showed that inhibition of 
follicle growth and induction of atresia were rescued in AHRKO compared to WT follicles. 
Collectively, these data show that MXC acts through the AHR pathway to inhibit follicle growth 
and induce atresia in antral follicles of the ovary.  
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5.6 Figures and Legends 
Figure 5.1 Effect of in vitro MXC exposure on XRE reporter activity  
 
 
 
Granulosa cells (GCs) were collected from ovaries of CD-1 mice, transfected with negative or 
positive or XRE-reporter plasmids and then treated with vehicle (DMSO), MXC (1-100 μg/ml), 
or TCDD (10 nM). Dual-glo luciferase reagent was added and luminescence was measured using 
luminometer.  Data represent means ± SE from 3 separate experiments (* indicates significant 
difference from vehicle controls; n=4-6 ovaries per experiment; p≤0.05).  
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Figure 5.2 Effect of in vitro MXC exposure on WT antral follicular growth 
 
 
 Antral follicles isolated from ovaries of WT mice were exposed to vehicle (DMSO) or MXC (1-
100 μg/ml) for 168 h. Growth of follicles was monitored during culture, recorded in μm and 
reported as percentage change. Data represent means ± SE from 3 separate experiments (* 
indicates significant difference from vehicle controls; n= 12-16 follicles per treatment; p≤0.05).  
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Figure 5.3 Effect of in vitro MXC exposure on AHRKO antral follicular growth 
 
 
 Antral follicles isolated from ovaries of AHRKO mice were exposed to vehicle (DMSO) or 
MXC (1-100 μg/ml) for 168 h. Growth of follicles was monitored during culture, recorded in μm 
and reported as percentage change. Data represent means ± SE from 3 separate experiments (* 
indicates significant difference from vehicle controls; a indicates significant difference from 
MXC 100 g/ml; n= 12-16 follicles per treatment; p≤0.05).  
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Figure 5.4 Effect of in vitro MXC exposure on atresia of WT and AHRKO antral follicles 
 
 
  
Antral follicles isolated from ovaries of WT or AHRKO mice were exposed to vehicle (DMSO) 
or MXC (1-100 μg/ml) for 168 h. At the end of culture, follicles were subjected to histological 
analysis of atresia. Data represent means ± SE from 3 separate experiments (* indicates significant 
difference between WT and AHRKO genotypes; Bars with different letters are significantly different 
from each other with in a genotype; n= 4 - 6 follicles per treatment; p≤0.05).  
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Figure 5.5 Effect of in vitro MXC exposure on estradiol (E2) levels 
 
 
 
Antral follicles isolated from ovaries of WT or AHRKO mice were exposed to vehicle (DMSO) 
or MXC (1-100 μg/ml) for 168 h. The media was subjected to measurements of E2 levels by 
enzyme-linked immunosorbent assay (ELISA). Data represents means ± SEM from 3 separate 
experiments (Bars with different letters are significantly different from each other with in a genotype; 
n= 10 - 12 follicles per treatment; p≤0.05).   
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Chapter VI 
 
6.1 Summary and Conclusion 
Summary 
The goal of my dissertation work was to broaden our knowledge of the mechanism of 
action of MXC in mouse ovarian antral follicles. Understanding the mechanism of action of 
MXC is important as it is a well known endocrine disrupting chemical (EDC), which affects 
fertility in different animal models and poses risks for humans as well as wild-life. Its endocrine 
disrupting capability decreases ovulation and decreases birth of live fetuses (Swartz and 
Eroschenko, 1998). MXC targets the ovary by causing ovarian atrophy, specifically targeting the 
antral follicles in the ovary (Eroschenko et al., 1995, 1997; Borgeest et al., 2002). MXC 
decreases the number of healthy antral follicles and increases the number of atretic follicles in 
the female mouse ovary. MXC also inhibits antral follicle growth and induces atresia in cultured 
antral follicles (Miller et al., 2005; Borgeest et al., 2002, 2004). These effects of MXC destroy 
antral follicles and increase the rate at which follicles are depleted from the ovary. Given the role 
of antral follicles in production of E2 for the physiological functions of the body, targeting 
follicles may increase the risks for other chronic diseases such as osteoporosis, early menopause, 
and reproductive senescence in humans or wildlife. Hence, the present study helps us to better 
understand the endocrine disruption mechanism of MXC in antral follicles by examining the 
effects of MXC on steroid levels, Bcl2 factors, and by determining if MXC exerts toxicity 
through an AHR pathway. Collectively, I found that MXC decreases steroid levels, alters Bcl2 
factors, and involves AHR pathway during its effects on antral follicles. 
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 In chapter III, I hypothesized that MXC decreases sex steroid hormone levels in antral 
follicles. In addition, I also tested the mechanism by which MXC alters steroidogenesis by 
examining the effects of MXC on steroidogenic as well as metabolic enzymes. I found that MXC 
decreases E2, testosterone, androstenedione, and progesterone hormone levels by decreasing 
most of the steroidogenic enzymes and increasing the metabolic enzyme Cyp1b1. In the liver, 
MXC is metabolized to 1,1,1-trichloro-2-(4-hydroxyphenyl)-2-(4-methoxyphenyl)ethane (MOH) 
and the bisphenolic compound 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane (HPTE) by 
cytochrome P450 (Cyp) 1a2 and 2c29 enzymes (Stresser and Kupfer, 1997; Stresser and Kupfer, 
1998). However, the MXC metabolites have not been measured in follicles. Given that antral 
follicles express metabolic enzymes Cyp1a2 and Cyp2c29 (Paulose et al., 2011), I did not test 
whether the effects of MXC on steroidogenesis are mainly due to MXC itself or MXC 
metabolites. Thus, future experiments should determine whether the effect of MXC on 
steroidgoenesis is due to MXC or its metabolites. In addition, future studies should determine the 
effects of MXC on protein levels of steroidogenic enzymes as the mRNA levels do not always 
represent protein levels. The present study did not test whether the effects of MXC on steroid 
levels are due to availability of substrate or down regulation of enzymes. Hence, future 
experiments should test the steroid levels and steroidogenic enzymes by using pregnenolone or 
cholesterol as a substrate in the culture. Since MXC increases Cyp1b1 in follicles, future 
experiments should also test whether follicles can be rescued from MXC toxicity by blocking 
Cyp1b1 using -napthoflavone.  
 In chapter IV, I tested the hypothesis that MXC induces atresia by altering pro-apoptotic 
and anti-apoptotic factors in the antral follicles of the ovary. Specifically, I examined the effects 
of MXC on mRNA expression of Bcl2, Bcl-xL, Bax, Bok, and Casp3 levels and caspase activity 
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after short and long term exposure. I found that, at 24 h, MXC mainly increases Bax and does not 
alter Bcl2; thus, increasing the Bax/Bcl2 ratio which in turn increases caspase activities. These 
changes together led to increased atresia in antral follicles at 48 and 96 h. We also found that 
MXC increases Bax (48 and 96 h), increases Bcl2 (96 h) and decreases in Bax/Bcl2 ratios (96 h) 
at later time points. This may be an attempt by the follicles to rescue themselves from MXC-
induced atresia. However, our data indicate that once MXC induces atresia at 48 h, the follicles 
cannot recover from atresia throughout the culture. It is likely that any increase in anti-apoptotic 
factor Bcl2 cannot compensate for pro-apoptotic effects of Bax. However, the present study did 
not examine the protein levels of these factors; hence future studies should consider measuring 
protein levels of Bcl2 family members using western blot or immunohistochemistry. Future 
studies should also determine if one can rescue follicles from MXC-induced atresia by inhibiting 
Bax or increasing Bcl2.   
 In chapter V, I tested the hypothesis that the AHR pathway is involved in mediating the 
effects of MXC treatment on antral follicles of the mouse ovary. Specifically, this study was 
designed to test the hypothesis that MXC works through the AHR to inhibit follicle growth and 
induce atresia. I found that MXC acts through the AHR pathway, inhibiting follicle growth and 
atresia in follicles. Since the present study was done using AHRKO and WT follicles in vitro and 
not in vivo, future studies should confirm the in vitro results by dosing AHRKO and WT mice 
with MXC. Given that follicle growth and atresia are restored in AHRKO antral follicles, future 
studies also should consider examining the effects of MXC on growth and atresia in AHR 
overexpressing follicles.  
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Conclusion 
A final model describing the main findings from my work and how they intergrate with 
previous findings on MXC is shown below (Figure 6.1).   
In the present study, at 24 h, MXC did not alter atresia and E2 levels. It did, however, 
increase Bax expression without changing Bcl2 expression; thus, increasing the Bax/Bcl2 ratio, 
which likely increased caspase activities. Since an increase in the Bax/Bcl-2 ratio and an increase 
in caspase activity are good markers of apoptosis, I think that MXC first causes apoptosis and 
this eventually leads to death of follicles and as a consequence, reduced steroid levels.   The 
mechanism by which MXC increases the Bax/Bcl2 ratio is unknown, but it may involve the 
ability of MXC to induce oxidative stress.  Previous studies have shown that MXC induces 
oxidative stress and that oxidative stress can cause apoptosis and atresia (Gupta et al., 2006b).  It 
would be interesting for future studies to examine whether the increased Bax/Bcl2 ratio precedes 
the production of reactive oxidative species in MXC-treated follicles.  Further, it would be 
interesting to see if blocking the MXC-induced increase in Bax by using Bax knockout mice or 
Bax anti-sense protects follicles from MXC induced atresia and/or oxidative stress. By 48 h and 
96 h, I observed that MXC decreases E2 levels (MXC 1, 10, 100 μg/ml) and continues to 
increases atresia (MXC 1, 10, 100 μg/ml). These data suggest that the effects of MXC on 
steroidogenesis come after the effects of MXC on atresia and that the effects of MXC on atresia 
continue over time.   These data are consistent with previous studies that show that MXC inhibits 
cell cycle regulators (Gupta et al., 2009).  Studies indicate that inhibition of cell cycle regulators 
can cause cells to exit the growth cycle and enter the apoptotic pathway (Sicinski et al., 1996).  
Thus, it is possible that MXC inhibits cell cycle regulators and this pushes follicles towards 
atresia.  Alternatively, it is possible that MXC causes atrtesia first and this leads to the decrease 
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in cell cycle regulator.  Future studies should examine the time course by which MXC inhibits 
cell cycle regulators to help distinguish between these possibilities. 
Finally, my work indicates that MXC may partially work through an AHR pathway 
because deletion of the AHR protects follicles from MXC-induced atresia and growth inhibition 
at the 10 g/ml MXC dose.  It is important to note, however, that AHR deletion does not protect 
follicles from MXC at high doses nor does it protect follicles from MXC-induced inhibition of 
steroidogenesis.  These data suggest that MXC may work through other receptor pathways in 
addition to the AHR.  Perhaps, at lower doses, MXC mainly works through an AHR pathway, 
but at higher doses, it may work through additional pathways.  Since previous studies suggest 
that MXC may bind to estrogen and androgen receptors (Miller et al., 2006; Ghosh et al., 1999; 
Waters et al., 2001), future studies should examine whether MXC-induced atresia, inhibition of 
follicle growth, and reduced steroidogenesis involve estrogen receptor or androgen receptor 
pathways. Thus, the chemical kills follicles and inhibits steroidogenesis over time.   
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6.2 Figures 
Figure 6.1 Final model of mechanism of action of MXC in antral follicles. 
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